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Understanding normal liver development is critical for the production of cell therapies for treating 
liver disease and also for the construction of in vitro liver models. During the progress of the 
research described in this thesis I specifically addressed the role of the Wnt/-catenin pathway in 
liver development and also the effect of ectopic expression of liver-enriched transcription factors on 
the conversion of pancreatic cells to hepatocyte-like cells.    
The Wnt pathway is known to play a critical role in the maintenance of the zonation of ammonia 
metabolizing enzymes in the adult liver. Herein we determined the spatiotemporal role of the 
Wnt/-catenin pathway in the development of zonation in embryonic mouse liver. We initially 
examined the expression of Wnt ligands (Wnt4, Wnt5a, Wnt5b and Wnt9), receptors (Frizzled1, 
Frizzled2 and LRP5) and two hepatic zonation markers, the periportal marker and urea cycle enzyme 
carbamoylphosphate synthetase (CPS) and the perivenous enzyme Glutamine synthetase (GS) at 
different stages of liver development by in situ hybridization, immunohistochemistry and western 
blotting. We observed temporal changes in the Wnt signalling molecules. In addition, we found that 
CPS became expressed between E14.5 and E15.5 and gradually the number of cells expressing the 
enzyme increased during development. Nuclear -catenin and GS were expressed between E17.5 and 
E18.5 of liver development in a complementary fashion to the CPS-expressing cells.   
In order to examine the effect of activating the Wnt/-catenin pathway during liver development, 
conditional deletion of Apc was induced at different time points during liver development and the 
expression of periportal and perivenous hepatocyte and ductal markers determined by PCR and 
immunohistochemical techniques. Conditional loss of Apc resulted in the expression of nuclear 
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-catenin throughout the developing liver. This was accompanied by a reduction in the expression of 
CPS and up-regulation of GS expression. When Apc loss was induced at around E16.5 and liver 
samples were collected at E18.5, we also observed an upregulation of the ductal phenotype.  
To extend these studies we examined the direct role of the Wnt/-catenin pathway on development 
of liver zonation regulation by infecting in vitro cultures of embryonic mouse livers with adenoviral 
vectors expressing Wnt1 and Wnt5a. The results demonstrated that ectopic expression of Wnt1 and 
Wnt5a enhances the perivenous phenotype. 
Transdifferentiation is the conversion of one differentiated cell type to another and a number of in 
vitro models have been developed for converting pancreatic cells to hepatocytes, including culturing 
the rat pancreatic amphicrine call line AR42J-B13 (B13) with synthetic glucocorticoid 
dexamethasone (Dex). CCAAT-enhancer binding proteins (C/EBP)-β has been identified as part of 
the molecular basis of the switch however it did not cause the same degree of morphological 
flattening as Dex. To test the role of hepatic nuclear factor (HNF4)-in Dex induced 
transdifferentiation, we co-expressed C/EBP and HNF4 in B13 cells by using adenoviral infection. 
The results showed that ectopic expressed HNF4 and C/EBPcould induce the expression of 
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1.1 Liver development 
The liver is the largest gland in the body and exhibits both endocrine and exocrine properties. The 
endocrine functions include the secretion of several hormones including insulin-like growth factor I 
and II, angiotensinogen and thrombopoietin, while the major exocrine secretion of the liver is in the 
form of bile. The liver is also responsible for detoxification and metabolism of drugs and toxins and 
their subsequent elimination and the regulation of intermediary metabolism through the co-ordinated 
regulation of carbohydrate, fat and protein metabolism (Haubrich et al., 1995; Zakim and 
Dannenberg, 1990). 
The principal functional cell type of the liver is the parenchymal hepatocyte, which accounts for 78% 
of volume in the rat liver (Blouin et al., 1977). The hepatocyte is a polarized epithelial cell with 
apical and basolateral surfaces. The basolateral surface faces onto the sinusoids. Sinusoids are the 
blood vessels that supply the hepatocytes and are lined by endothelial cells. The hepatocyte does not 
have a basement membrane instead there is a space between the basolateral surface of the hepatocyte 
and the sinusoidal endothelial cell. Moreover, the basement membranelike extracellular matrix (ECM) 
underlying sinusoidal endothelial cells have a low-density structure that minimally impedes 
sinusoid-hepatocyte exchange (Hahn et al., 1980; Kmiec, 2001). This arrangement facilitates the 
endocrine-like function of the liver, which is to condition the venous blood, received from the 
digestive tract, through secretion of plasma proteins and removal of toxic products.  The apical 
surface of the hepatocyte forms the bile canaliculus, the smallest branch of the biliary tree. Tight 
junction proteins, including occludin, claudin and ZO-1, seal the apical domains of two adjacent 
hepatocytes, helping to create the bile canaliculus (Vinken et al., 2006). Biliary epithelial cells 
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(cholangiocytes), sinusoidal endothelial cells, hepatic stellate cells (Ito cells), Kupffer cells, and pit 
cells (liver-specific natural killer cells) represent the majority of non-hepatocyte (non-parenchymal) 
cell types in the liver. Hepatocytes and biliary epithelial cells originate from a common precursor, 
the hepatoblast that derives from the definitive endoderm (Douarin, 1975). 
The parenchymal cells of the liver derive from the anterior portion of definitive endoderm which 
emerges from the primitive streak to displace the extra embryonic endoderm of the yolk sac at 
around mouse embryonic day 7 (Tremblay and Zaret, 2005).  
Prior to specification (at mouse embryonic day (E) 8.25, 3-4 somite stage), there are three distinct 
fated domains of hepatic progenitor cells that are located in the medial and bilateral regions of the 
foregut (Figure 1.1A) (Tremblay and Zaret, 2005). Hepatic differentiation begins in the ventral 
foregut endoderm immediately after the endothelium interacts with cardiac mesoderm, around the 6 
somite stage of embryogenesis (E8-8.5) [Figure 1.1B (a)]. During foregut closure, the medial and 
lateral domains come together (Figure 1.1A, green arrows) as the hepatic endoderm is specified. The 
progenitor cells within these regions converge to lie adjacent to the developing heart and in close 
position to regions of lateral plate mesoderm that will ultimately generate the mesothelial cells of 
proepicardium and septum transversum (LeDouarin, 1975(Medlock and Haar, 1983) The newly specified 
cells then proliferate within the epithelial layer, while morphogenetic extension of the foregut pulls 
the hepatic endoderm away from the heart region, towards to the midgut [Figure 1.1B (b)]. It is at 
this time that a family of transcription factors, the Foxas (previously known as hepatocyte nuclear 
factor (HNF) 3) (Dufort et al., 1998), specifies the endoderm to express hepatic genes. Foxa proteins 
are considered to function as ‘pioneer proteins’ in that they attach early on during development to 
silent (hypoacetylated) chromatin (Zaret, 1999). This enables competence that will allow the 
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attachment of other liver-specific transcription factors and the subsequent induction of hepatic 
pattern of gene expression (Cirillo et al., 2002). A subclass of GATA zinc-finger transcription factors 
(GATA4) also has a pioneer role in liver-specific gene expression (Bossard and Zaret, 1998). The 
presence of both Foxa and GATA persists up to E11.5 acting together as potentiators of hepatic fate 
by generating a receptive chromatin structure that surrounds ‘hepatic’ enhancers (Cirillo et,al, 2002). 
The change in chromatin structure allows the enhancers to be occupied by other transcription 
activators such as CCAAT/enhancer-binding protein (C/EBP) and nuclear factor 1 (NF1) 
subsequently activating the albumin promoter (Block et al., 2003; Cirillo et al., 2002). 
Around embryonic day 9 (10–12 somite stage), the liver epithelial cells proliferate and migrate in a 
cord-like fashion into the mesenchyme of septum transversum, and at this stage of development the 
liver bud can be seen as an outgrowth of hepatoblasts (Perez-Pomares et al., 2004)[Figure 1.1B (C)]. 
The hepatoblasts in the liver bud are bipotential, giving rise to both hepatocytes and bile duct 
epithelial cells (BEC). The septum transversum mesenchyme contributes endothelial cells and 
stellate cells that form and line the sinusoids (Gouysse et al., 2002). The hepatic vasculature develops 
as the liver bud grows. Vasculogenic endothelial cells and nascent vessels are critical for liver 
morphogenesis and will ultimately help establish the cellular architecture that is important for normal 
liver function (Matsumoto et al., 2001). By embryonic day 10.5, the liver is the main site of 
haematopoietic and ultimately well over 50% of the liver mass by mid-gestation is made-up of 
haematopoietic cells (Shiojiri and Sugiyama, 2004).  
Studies indicated that fibroblast growth factor 1 (FGF1) and FGF2, by themselves, could initiate 
hepatic development of the ventral endoderm (Jung et al., 1999). In addition to FGFs, bone 
morphogenic proteins (BMPs, members of the TGF-β superfamily) also contribute to the induction 
25 
 
of hepatogenesis. BMPs are produced at high levels in the septum transversum, suggesting that these 
mesenchymal cells are also required for the commitment of foregut endoderm to a hepatic fate (Rossi 
et al., 2001). Recent studies demonstrated that BMPs, TGF-β signalling formed dynamic inductive 
network regulated the formation of pancreas and liver progenitors (Wandzioch and Zaret, 2009). 
Flexibility in hepatic programming, in that the prospective lateral hepatic progenitors receive 
FGF signalling prior to that for BMP, whereas the prospective medial hepatic progenitors receive 
BMP signalling prior to that for FGF has been suggested. Regardless of this marked difference, 
descendants of both progenitor cell types activate Afp and Hnf4 in the nascent liver bud 
(Wandzioch and Zaret, 2009).  
During the perinatal period, numerous changes take place in the liver. Haematopoiesis , which is a 
major function of the fetal liver, declines dramatically as haematopoietic stem cells migrate to the 
bone marrow (Johnson and Moore, 1975). Hepatoblasts, which are highly proliferative in the fetal 
period, become quiescent. As expected, many cell cycle regulated genes are silenced during this 
period. In addition, a number of liver-enriched genes such as Afp and H19 are silenced at birth 
(Spear et al., 2006). In contrast, many enzymes, including those involved in intermediary metabolism 
and detoxification must be induced (Callikan and Girard, 1979). The lobular architecture of the liver 
is established during the perinatal period, along with zonal control of gene expression (Notenboom et 
al., 1996). 
The hematopoietic system is established at specific sites in the embryo through a succession of 
developmental programs that result in the generation of distinct precursor colony-forming cells (CFC) 
that in turn produce all the differentiated blood cells that enter the circulation. The first 
hematopoietic cells in the mouse embryo arise in blood islands that form from extraembryonic 
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mesoderm at the neural plate stage of development at embryonic day 7.5 (E7.5) (Haar and Ackerman, 
1971). These primitive erythroblasts derived from the yolk sac represent the predominant mature 
blood cells in the early circulation and differ from erythrocytes derived later from the fetal liver and 
bone marrow. Primitive erythroblasts are large, nucleated cells that synthesize embryonic globins 
(Barker, 1968; Steiner and Vogel, 1973). Definitive erythropoiesis is established in the liver 
beginning at 28-32 somite pairs (E9.5)(Houssaint, 1981), and results in the generation of small, 
enucleate erythrocytes that synthesize the adult forms of globin. In contrast to the yolk sac’s 
restricted hematopoiesis, fetal liver hematopoiesis is multilineage and includes the differentiation of 
definitive erythroid, myeloid, megakaryocyte and lymphoid cells (Moore and Metcalf, 1970). Guo 
and colleagues found that E11.5-E14.5 corresponds to a fetal liver hematopoietic expansion phase 
with distinct molecular features, including the expression of KRAB (Kruppel-associated 
box)-containing zinc finger proteins which are known to affect bone marrow hematopoiesis (Guo et 
al., 2009). Late in fetal life, hematopoietic activity initiates in the bone marrow which, shortly after 
birth, becomes the predominant site of blood cell production for the duration of postnatal life. 
Previous studies indicated an important role of Wnt signalling in regulating hematopoiesis during 
mammalian development (Staal and Clevers, 2005). Expression of Fz5, Wnt5a and Wnt10b has been 
found in both mouse embryonic yolk sac and fetal liver. Mice homozygous for a null mutation of Fz5 
die at E10.75 due to defect of yolk sac angiogenesis and reduced proliferation of endothelial cells in 
the yolk sac can be observed at earlier stages (Ishikawa et al., 2001). Wnt10b was also found to be 
expressed by murine fetal liver hematopoietic progenitors (Austin et al., 1997). The progenitor cell 






Figure 1.1 Early stages of embryonic liver development 
A. Fate map of cell domains before tissue induction (mouse embryos at 3-4 somites stage or E8.25). 
Green arrows indicate movement of lateral progenitor regions toward the ventral-medial region. 
B. Formation of the liver bud. (a) In about 6 somites stage embryo, cardiac mesoderm induces (arrow) 
the foregut endoderm to activate liver specific genes (white blocks). (b) As the mesoderm is pulled 
towards the midgut during gut closure, the early hepatocytes begin to proliferate within endoderm 
layer. (c) The early hepatocytes migrate into a region of loose mesenchyme (referred to as the 
septum transversum). The early hepatocytes then coalesce around the sinusoids in the mesenchyme, 
forming the liver organ (Zaret, 1998; Zaret and Grompe, 2008).  
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1.2 Liver zonation 
Establishment of the lobular liver architecture during the perinatal period is accompanied by zonal 
gene regulation. This compartmentalization of function is determined by the position of hepatocytes 
within the lobule, the microanatomical organization of the smallest functional unit of the liver 
(Braeuning et al., 2006; Jungermann and Katz, 1989). The unit is divided into three zones: the 
periportal zone, which surrounds the afferent vessel and portal triad and receives blood rich in 
oxygen and nutrients, the intermediate zone, which surrounds the periportal zone and finally the 
outer, perivenous zone (Figure 1.2). The expression of key rate-limiting enzymes are 
heterogeneously distributed across the lobule with some liver enzymes bring more highly expressed 
in periportal regions whereas other enzymes are preferentially expressed in pericentral regions. For 
example, the activities of key rate-limiting enzymes for some pathways e.g. gluconeogenesis 
(glucose-6-phosphatase) are higher in the periportal zone whereas the activities of other enzymes e.g. 
glycolytic (glucokinase) enzymes are higher in the perivenous zone (Katz et al., 1977). 
Consequently, most of the major hepatic functions exhibit differences in activity within the periportal 
and perivenous zones. For example, metabolism of drugs and xenobiotics also display well defined 
zonation (Lindros, 1997), The cytochrome P450 system is responsible for the conversion of 
xenobiotics into more readily excretable products. This involves monooxygenation followed by 
conjugation with either glucuronic acid or sulfuric acid. Monooxygenation mainly occurs in the 
perivenous zone, with glucuronidation as the major conjugation reaction in these cells, whereas 
sulfotransferase which are involved in sulfation showed heterogeneous expression in periportal and 
perivenous hepatocytes (Buhler et al., 1992; Lindros, 1997; Tosh et al., 1996). Other zonated 
processes include: lipid metabolism, with lipogenesis occurring perivenously and fatty-acid 
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degradation periportally (Braeuning et al., 2006); Cyp7a1-mediated synthesis of bile acids derived 
from cholesterol, showing clear perivenous zonation (Berkowitz et al., 1995); and the metabolism of 
several amino acids, the catabolism of histidine and serine being mostly periportal, and glutamine 
synthesis (associated with ammonia detoxification) being perivenous. 
While the gradients of function mentioned above are pronounced, perhaps the most striking example 
of zonation is observed in the enzymes and pathways of ammonia detoxification. The liver contains 
two systems for the removal of ammonia: the urea cycle and the enzyme glutamine synthetase (GS).  
The urea cycle (Table 1-1) is a cycle of biochemical reactions occurring in many animals that 
produces urea CO(NH2)2 from ammonia (NH3). This cycle was one of the first metabolic cycles to be 
discovered by Hans Krebs and Kurt Henseleit in 1932. In mammals, the urea cycle takes place only 
in the liver. The urea cycle consists of five reactions - two mitochondrial and three cytosolic. The 
cycle converts two amino groups, one from NH4
+
 and one from Aspartate, and a carbon atom from 
HCO3
-,
 into the relatively nontoxic excretion product, urea, at the cost of four "high-energy" 
phosphate bonds (3 ATP molecules are hydrolyzed to 2 ADP molecules and one AMP molecule). 
Ornithine (Orn) is the carrier for the carbon and nitrogen atoms. 
Carbamoylphosphate synthetase I (CPS) is the rate-limiting enzyme in the urea cycle, a well-studied 
example of periportal expression (Dingemanse et al., 1996). The combined capacity of the urea cycle 
and glutamine synthetase (GS) systems allows the liver to effectively regulate blood ammonia level 
within narrow limits. Glutamine synthetase catalyses the ATP-dependent formation of glutamine 




Table 1-1 Reactions of the urea cycle 
Step Reactant Product Catalyzed by Location 





Carbamoyl phosphate + 2ADP + Pi CPS1 mitochondria 
2 
Carbamoyl phosphate + 
Ornithine 
Citrulline + Pi OTC mitochondria 
3 
Citrulline + Aspartate + 
ATP 
Argininosuccinate + AMP + PPi ASS cytosol 
4 Argininosuccinate Arginin + Fumarate ASL cytosol 
5 Arginin + H2O Ornithine + Urea ARG1  cytosol 
Enzymes in the urea cycle: Carbamoylphosphate synthetase (CPS1), Ornithine transcarbamoylase 
(OTC), Argininosuccinate synthetase (ASS), Argininosuccinate lyase (ASL) and Arginase 1 (ARG1) 
As blood ammonia levels in the blood accumulate (e.g. during hyperammonemic conditions arising 
from diseases such as liver failure and inborn errors of the urea cycle) the levels in the brain also 
increase reaching toxic levels (Cooper and Plum, 1987). Ammonia is a metabolite which is mostly 
produced within the gut during protein digestion and deamination. The urea cycle within the liver 
regulates the concentration of ammonia in the systemic circulation maintaining blood ammonia 
levels in the 50–100M range. Therefore, reduced hepatic capacity for ammonia removal leads to 
hyperammonemia which is a metabolic disturbance characterised by an excess of ammonia in the 
blood may lead to  increased levels of brain ammonia and consequently a spectrum of central 
nervous system dysfunction and encephalopathy including impaired memory, shortened attention 
span, sleep-wake inversions, brain oedema, intracranial hypertension, seizures, ataxia and coma. 
During liver failure, brain ammonia concentrations can reach 1-5mM. Many deaths of patients with 
liver failure occur due to neurological complications such as brain oedema, increased intracranial 
pressure and brain stem herniation.  These symptoms have been demonstrated to be related to 
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arterial ammonia concentrations in both clinical (Bernal et al., 2007; Bhatia and Mihas, 2006) and 
animal studies (Jover et al., 2006; Sen et al., 2006). 
Several models have been proposed to account for zonal regulation in the adult liver. The 
differentiation model proposes that expression of genes is dependent on the developmental status of 
the hepatocyte (Sigal et al., 1992). This model suggests that liver is organized with three 
compartments: a slow cycling stem cell compartment; an amplification compartment with cells 
rapidly proliferating in response to regenerative stimuli; and a terminal differentiated cell 
compartment. The developmental status of cells along the portocentral axis dictates the gene 
expression, and is based on evidence that putative hepatic stem cells exist in portal triads and those 
hepatocytes adjacent to the portal triads are the least differentiated, whereas hepatocytes around the 
central veins are terminally differentiated. The various compartments positioned in a polarized 
organization are associated with a gradient in the chemistry of extracellular matrix, gene expression, 
pharmacological and toxicological response. A support of the differentiation model is the Streaming 
Liver Hypothesis (Zajicek et al., 1985). Here, the hepatic stem cells become more differentiated as 
they migrate from the portal region towards the central veins. While there is evidence that hepatic 
stem cells exist in the portal regions, strong experimental data argues that neither the developmental 
nor streaming models can account for all zonal gene regulation (Bralet et al., 1994). It has also been 
suggested that cell-cell or cell-matrix interactions could account for zonal patterns of expression 
(Kuo and Darnell, 1991). For example, by observation of GS mRNA expression during the 
regeneration after surgical removal of two-third of the liver and the treatment with carbon 
tetrachloride which specifically kills pericentral hepatocytes, only hepatocytes resumed contact with 
pericentral veins were the high level of GS transcription restored. Therefore interactions between 
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central vein endothelial cells and pericentral hepatocytes were suggested to be account for GS 
expression. While this model might explain expression of GS, it is hard to envisage how this 
mechanism could account for other zonal gene expression. It has also been proposed that the 
directional flow of blood along the sinusoids in a portocentral direction could govern zonal gene 
expression (Jungermann and Kietzmann, 1996). Blood enters the portal triad rich in oxygen, 
nutrients and hormones. The concentration of these substances changes as blood flows towards the 
central veins. Although blood-borne molecules may account for zonal regulation these have not yet 
been firmly identified, this remains the most widely accepted model to account for 
position-dependent gene expression. As pointed out by Lamers and colleagues (Christoffels et al., 
1999), gradual changes in regulatory molecules could account for both gradient (gradual) and 
compartment (well-defined) patterns of expression, depending on how the extracellular stimuli are 
integrated into the transcriptional machinery that lead to zonal control. Recently, a role of 
Wnt/-catenin signalling pathway in maintenance of hepatic zonation in adult mice has been 
established (Benhamouche et al, 2006; Burke et al, 2009). Further details of the role of the 





Figure 1.2 Schematic diagram of the microanatomical unit of the liver 
Each liver acinus assumes a roughly hexagonal shape with hepatocytes radiating out from the central 
vein. This architecture is repeated throughout the liver plate with portal triads [composed of a branch 
of the hepatic artery (HA), portal vein (PV) and bile duct (BD)] placed at regular intervals between 
the acinii. Along the portovenous axis, hepatocytes can be divided into three zones: periportal, 
intermediate and perivenous. Gradients in metabolic pathways such as gluconeogenesis, glycolysis, 
xenobiotic metabolism, lipogenesis and ammonia metabolism are observed along this axis. Cells of 
the proximal perivenous zone express glutamine synthetase (red) while the remaining hepatocytes 






1.3 Wnt/-catenin signalling pathway 
The Wnt signalling pathway plays a central role in embryonic development, maintenance of adult 
stem cells (e.g. intestinal stem cells) and the progression of human tumours of multiple tissues, 
including the brain, breast, colon, skin, and liver (Cadigan and Nusse, 1997). In the liver, -catenin 
appears to be an active player in hepatoblastomas, benign liver neoplasms, hepatocellular carcinoma, 
and cholangiocarcinomas (Thompson and Monga, 2007). 
The Wnt genes encode a large family of secreted glycoproteins, homologous to wingless in 
Drosophila, that signal at the cell surface via at least two receptors: Frizzled, a seven-pass 
transmembrane domain-containing serpentine protein and the Low-density-lipoprotein-related 
protein (LRP) receptor (Table 1-2). Transduction of the Wnt signal is mediated through three distinct 
pathways: the canonical Wnt pathway dependent upon activation of -catenin, the Wnt/Ca2+ pathway 
and the Wnt/PCP (planar cell polarity) pathway (Kikuchi et al., 2006). The Wnt glycoproteins are 
produced by the neighbouring cells and secreted in a process that involves components, such as a 
multiprotein retromer complex and the multispanning transmembrane protein Wntless (Wls). The 
secreted Wnt ligands bind to the receptors of the seven-membrane-spanning Frizzled family and 
single-spanning LRP family. Secreted factors such as secreted Frizzled-related proteins (sFRPs) bind 
to Wnts and block the interaction with Frizzled receptors. Also Dickkopf (DKK) antagonizes Wnt 
signalling by blocking the LRP receptors. In the canonical Wnt pathway (Figure 1.3), the 
Wnt-Frizzled-LRP complex leads to the recruitment and phosphorylation of the cytoplasmic protein 
Dishevelled, a key transducer of the Wnt signal. Subsequently, glycogen synthase kinase 3 
(GSK3 and Axin, two proteins that form part of a complex with the tumour suppressor protein 
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adenomatous polyposis coli (APC) that normally directs the phosphorylation and ubiquitination of 
-catenin, are inhibited and degraded.  In the absence of the APC protein complex, free cytoplasmic 
-catenin is un-phosphorylated on threonine 41 and serines 33, 37, and 45 by a protein complex 
comprised of glycogen synthase kinase 3  (GSK3) and CK (casein kinase)(Rubinfeld et al., 1996; 
Yost et al., 1996), and can then accumulate and enter the nucleus, where it forms a transcriptionally 
active complex with T cell factor (TCF)/Lymohocyte enhancer factor (LEF) family of transcription 
factors. The transcriptional complex can then replace Groucho from chromatin, and interacting with 
other coactivators like CREB binding protein (CBP), B cell lymphocyte 9 (BCL9), and Pygopus. 
Signalling through this pathway is very much dependent upon the level of -catenin within the cell 
(Miller et al., 1999). The three pathways branch at the level of Dishevelled (Dsh) protein. In the 
non-canonical jun N-terminal kinase (JNK) pathway, Dsh (via Dishevelled-associated activator of 
morphogenesis 1 (Daam1)), is connected to downstream effectors, such as Rho, and regulates 
cytoskeletal organization and cell polarity. The Wnt/Ca
2+
 pathway leads to the release of intracellular 
calcium, and involves activation of Phospholipase C (PLC) and protein kinase C (PKC). Ca
2+
 is also 
important as it can activate Calmodulin-dependent protein kinase C (CaMKII), and Nemo-like kinase 









Table 1-2 Summary of the Wnt ligands, receptors and antagonists 
Ligands Pathway Receptors Pathways Antagonists 
Wnt1 Canonical Fzd1 Canonical Sfrp1   
Wnt2  Fzd2 Noncanonical Sfrp2   
Wnt2b Noncanonical Fzd3 Noncanonical Sfrp3/Frzb   
Wnt3 Canonical Fzd4 Noncanonical Sfrp4   
Wn3a Canonical Fzd5 Canonical Sfrp5   
Wnt4 Canonical Noncanonical Fzd6 Noncanonical Wisp1   
Wnt5a Noncanonical Fzd7 Canonical Wisp2   
Wnt5b Noncanonical Fzd8  Wisp3   
Wnt6 Canonical Noncanonical Fzd9 Canonical Dkk1   
Wnt7a (Maybe Wnt/PCP) Fzd10  Dnn2   
Wnt7b  Fzd11  Dkk3   
Wnt8a Canonical   Dkk4   
Wnt8b Canonical LRP5 Canonical Noncanonical Wif1   
Wnt9a  LRP6 Canonical Noncanonical   












1.4 Wnt/-catenin signalling in liver 
development 
The Wnt signalling pathway may play a key role during liver development. Ober and co-workers 
recently demonstrated the requirement for mesodermally-derived Wnt signalling to direct liver 
specification in the zebrafish embryo (Ober et al., 2006). An analysis of the zebrafish mutant 
Prometheus points to a previously unknown role for Wnts during liver specification. Prometheus 
(prt) mutant was generated by Ober et al (Ober et al, 2006) used a forward genetics approach 
involving N-ethyl-N-nitrosourea (ENU) mutagenesis of the transgenic zebrafish line 
Tg(gutGFP)s854. In this line, green fluorescent protein (GFP) is used as a reporter and is expressed 
throughout the developing endoderm. The prt mutants exhibit defective hepatic fate specification and 
the liver is either absent or strongly reduced. This is accompanied by reduced or no expression of the 
early hepatoblast markers hhex (haematopoietic ally expressed homeobox) and prox1 
(prospero-related homeobox 1). These genes normally mark the early phase of liver formation. 
Positional cloning revealed that the prt gene encodes a novel Wnt2b homologue, named Wnt2bb. 
This is the first example of genetic evidence to show the role for Wnt signalling in liver formation. 
The expression of the secreted frizzled-related protein 5 (sfrp5) gene, which encodes a Wnt inhibitor, 
is expressed in the mouse foregut endoderm (Finley et al., 2003) suggesting that inhibition of the 
Wnt pathway may be required during hepatic specification. Further experiments demonstrated that 
interactions between Wnt11 and the Sfrp5 protein can coordinate cell fate and morphogenesis during 
Xenopus foregut development. Depletion of Sfrp5 results in reduced foregut gene expression, 
hypoplastic liver and ventral pancreatic buds. It is possible that finely executed waves of inhibition 
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and activation of Wnt signalling may mediate the various stages of endoderm patterning, such as 
liver development, or that convergence of other pathways known to operate during this time, such as 
BMP signalling, may act to enhance the Wnt pathway, as BMP2 enhances Wnt2b expression in 
keratinocytes (Yang et al., 2006). Interestingly, FGF8 and BMP4 are essential for hepatic induction 
and differentiation and both are known targets of Wnt signalling (Kawakami et al., 2001). Whether 
these factors act downstream or in a feedback loop with an earlier temporal specifying Wnt signal in 
the mouse liver remain to be elucidated. The role for Wnt/-catenin pathway in developing liver has 
been further studied recently. Livers from mouse embryos cultured with -catenin antisense 
oligonucleotides showed a decrease in proliferation and a simultaneous increase in apoptosis, two 
vital processes in liver development (Tan et al, 2006). This correlated well with a study that found 
that overexpression of -catenin in developing chicken livers leads to a three-fold increase in liver 
size (Suksaweang et al., 2004). This effect on cell proliferation might be mediated by downstream 
targets such as cyclin D1 that regulates G1/S transition in cell cycle, which is also know downstream 
target of -catenin. Thus, -catenin is likely playing an important role during early liver development 
in hepatocyte expansion via its transcriptional co-activator role.  
It has also been shown that the temporal expression of -catenin during mouse liver development 
with high levels at E10-E14 along with its nuclear location in hepatoblasts, which correlated with 
increased cell proliferation. Microarray, Northern blotting, and protein analyses showed peak 
expression of -catenin during early liver development at E10-E12, followed by a decrease and a 
complete loss of normal -catenin after E16 through the remaining prenatal period. At the early 
stages, -catenin localized to the cytoplasm and nuclei of resident cells in addition to its normal 
membranous localization, which was seen at all later stages and in adult liver. Decreases in -catenin 
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levels at E14 onward coincided with its decreased gene expression and increased degradation 
(Micsenyi et al., 2004). This membranous localization and functional complex with its partners 
E-cadherin and Met might be a hallmark of acquisition of hepatocytic maturation and polarity. 
Indeed, antisense ablation of -catenin promoted a more immature cell type that continued to 
coexpress stem cell and mature hepatocyte markers (Monga et al., 2003). Additionally, studies using 
Matrigel in primary hepatocyte cultures showed an increase in membranous complexes as a part of 
the differentiation process (Monga et al., 2006). This indicates that hepatocyte maturation might be a 
function of the cell-cell adhesion properties of -catenin with some contribution from its 
transcriptional coactivator function. The latter function might be associated with the function of 
-catenin in regulating expression of genes involved in hepatocyte maturation, such as the 
cytochrome P450s, shown recently to be tentative targets of the Wnt/-catenin pathway in liver 
(Sekine et al., 2006).  
-catenin has also been shown to play a role in biliary specification during liver development. 
-catenin antisense ablation in E10 liver cultures led to an absence of cytokeratin kinase-positive 
biliary cells (Monga et al, 2003). Conversely, growth in Wnt3a-conditioned media showed survival 
and proliferation of predominantly Cytokeratin 19-positive cells as compared with the control media 
or Wnt3a-conditioned media containing soluble Frizzled-related protein-1 (sFRP1), a Wnt inhibitor 
(Hussain et al, 2004). Thus, -catenin appears to play multiple important roles during hepatic 
morphogenesis based on in vitro and limited in vivo analysis, although whether such observations 
would hold true during in vivo gene targeting approaches for -catenin or upstream effectors remains 
to be seen.  
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In order to further investigate the role for Wnt/-catenin signalling in the embryonic liver Decaens et 
al applied conditional deletion strategy using Cre recombinase under the control of Cre/locus of 
X-over P1 (loxP) system to perform adenomatous polyposis coli (Apc) deletion in hepatoblasts 
(Decaens et al., 2008). The Cre recombinase was under the control of a chimeric 
-fetoprotein-albumin enhancer/promoter. The loss of Apc and accumulation of -catenin protein 
were detected in clusters of cells from E11.5 in Apc
-/-hb
 livers and led to embryonic lethality between 
E16.5 and E18.5. Because -catenin has been shown to regulate proliferation and survival of resident 
cells in ex vivo experiment for liver development (Micsenyi et al, 2004), liver hypoplasia due to 
severe impairment of proliferation as shown by the lack of Ki67 staining was an unexpected 
consequence of activation of the -catenin pathway in the liver. However by using qPCR the authors 
confirmed that some genes with a positive impact on proliferation, such as Ki-ras (v-Ki-ras2 Kirsten 
rat sarcoma viral oncogene homolog (Kras2)), were preferentially down-regulated, whereas growth 
arrest-associated genes were up-regulated in Apc
-/-hb
 livers. Apc loss in the hepatoblast also showed 
both repression of the expression of hepatoblast markers and blockage of differentiation toward the 
hepatocyte lineage. A significant increase in the expression of cytokeratin genes cytokeratin-19 and 
cytokeratin-7, two hepatoblasts and cholangiocytes markers, were observed in both E12.5 and E14.5 
Apc
-/-hb
 livers by qPCR. However, no staining in Apc
-/-hb
 cell clusters and bile ducts with antibodies 
directed against cytokeratin-19 and cytokeratin-7 were observed. This implicated Apc deletion leaded 
to a partial commitment of Apc
-/-hb
 hepatoblasts to biliary lineage. While whole embryonic E14.5 
Apc
-/-hb
 livers labelled with cell tracker were transplanted into the livers of adult recipient mice, new 
bile ducts with embryonic origin stained with anti- cytokeratin-19 antibody were identified in the 
vicinity of adult portal spaces. According to these data, the activation of -catenin signalling in 
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hepatoblasts induces premature, mislocalized, and incomplete differentiation of these cells toward 
the biliary lineage.  
In contrast to the studies described above, Tan et al deleted -catenin in the developing hepatoblasts 
utilizing Foxa3-Cre and floxed--catenin transgenic mice from E8 to E8.5 (Tan et al., 2008). 
Deletion of -catenin in developing livers resulted in significantly underdeveloped livers after E12 
with lethality occurring at around the E17 stage of development. Histology revealed an overall 
deficient hepatocyte compartment due to increased cell death due to oxidative stress and apoptosis, 
and diminished expansion secondary to decreased cyclin-D1 and impaired proliferation. A paucity of 
primitive bile ducts was also observed. While no intrinsic defect in haematopoietic was observed, 
distorted hepatic architecture and deficient hepatocyte compartments resulted in defective endothelial 
cell organization was suggested to account for the overall foetal pallor. 
1.4.1 The role of Wnt/-catenin pathway in liver zonation 
It has been demonstrated that liver tumours in mice carrying activating mutations in -catenin 
exhibit altered zonal gene expression (Hailfinger et al., 2006). That is, tumours carrying -catenin 
mutations express GS throughout the lesion, whereas Ha-ras tumours are negative for GS but express 
E-cadherin (a marker typical of a periportal phenotype). It is the observation, such as this, from liver 
tumours, that first hinted -catenin may be required for mediating the expression of zone-specific 
genes. Benhamouche and colleagues have established a role for the Wnt pathway in regulating the 
zonation of ammonia detoxification along the portovenous axis (Benhamouche et al., 2006). Initially 
the authors demonstrated complementary expression of active -catenin and APC proteins in 
wild-type liver where localization is restricted to the perivenous and periportal regions, respectively. 
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Based on this observation, it was proposed that, APC, acting by repressing the nuclear translocation 
of -catenin, may be responsible for mediating zonation of the urea cycle. To test this hypothesis, 
hepatic Apc inactivation transgenic mice were generated. Liver-specific inactivation of the Apc gene 
was achieved by crossing conditional mutant mice for Apc with TTR-CreTam mice. In this line, the 
transthyretin promoter drives liver-specific expression of a tamoxifen (Tam)-inducible Cre 
recombinase. Injection of the resulting Apc
lox/lox
 mice with a single dose of tamoxifen generates Apc 
koliv
 animals, in which the Apc gene is inactivated only in the liver. Hepatic Apc conditional deletion 
leads to a complete disappearance of the APC protein by 7 days postinjection and subsequent 
lethality of mice due to the development of severe hepatomegaly, hyperammonaemia and 
hyperglutaminaemia. The mice displayed profound changes in liver gene expression. Apc
 koliv
 mice 
exhibit a conversion of hepatocytes from a periportal to a perivenous phenotype with GS expression 
extending from the central vein to the portal triad throughout the liver. Additional genes and proteins 
(glutamate transporter-1, ornithine aminotransferase, leucocyte cell-derived chemotaxin-2, Axin2 
and Rnase4) normally only expressed in perivenous hepatocytes were also upregulated following 
loss of APC. Concomitant loss of periportal-specific markers such as CPS, Glutaminase2, Arginase1 
and PEPCK1 was also observed in the Apc 
ko
 mice. To further validate a role for the Wnt pathway in 
regulating zonation, Benhamouche et al infected wild-type mice with an adenoviral vector 
expressing the Wnt antagonist, Dickkopf 1 (DKK1). Inhibiting Wnt signalling led to a decrease in 
perivenous gene expression pattern and an increase in periportal markers, indicating that, while 
activation of -catenin is required for inducing a perivenous phenotype, inhibition of Wnt signalling 
mediates a periportal program of gene expression. However, in a small number of cells located in the 
proximal perivenous region, closest to the central vein, DKK1 is unable to overcome Wnt activation 
resulting in continued expression of GS. 
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Recently, using conditional deletion of Apc, -catenin, and c-Myc induced in the livers of mice our 
lab extended these observations to explore the role of 3 key components (Apc, -catenin, and c-Myc) 
of the Wnt pathway in the liver zonation of ammonia metabolizing enzymes (Burke et al., 2009). 
Conditional loss of Apc resulted in the expression of nuclear -catenin and GS in most hepatocytes 
irrespective of zone. Deletion of -catenin induced a loss of GS and a complementary increase in 
expression of CPS irrespective of whether Apc was present or not. However, deletion of c-Myc did 
not perturb the pattern of zonation. These results demonstrated that critically metabolic zonation is 
-catenin dependent but c-Myc independent. The subtle change in the zonation of the CPS and 
GS-expressing cells requires finely regulation of gradient distribution of -catenin /APC. Therefore 
additional components of the Wnt/-catenin pathway may be involved in maintaining the 
perivenous phenotype. 
The timing of -catenin expression may make it difficult to determine the mechanisms responsible 
for induction of metabolic zonation during liver development. CPS -expressing cells first appear at 
E13 and, with the exception of the area immediately around the hepatic veins, fill the entire lobe by 
E16. GS-expressing cells are detected at E17, in the small population of cells negative for CPS, thus 
recapitulating the zonation observed in adult liver (Spijkers et al., 2001). It has been proposed that 
maturation of periportal cells is required to induce the expression of a perivenous gene program 
during liver development. Interestingly, -catenin levels peak between E12 and E14, around the time 
when CPS expression is induced, but become undetectable by E18 (Micsenyi et al., 2004). If Wnt 
signalling is required for setting up periportal and perivenous gene expression programs during 
development, as well as maintaining them in adult liver, one might expect -catenin to be present at 
least in the region of the hepatic veins around E17 when GS-positive cells first appear. However, 
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-catenin levels remain undetectable until after birth suggesting that alternative signalling pathways 
operate to direct the development of the perivenous cell phenotype or more complicated mechanism 
underlying remained elucidated.  
 
1.5 Transdifferentiation 
1.5.1 The definition of transdifferentiation 
Transdifferentiation is the conversion of one differentiated cell type to another and may occur either 
directly (without an intervening cell division) or indirectly.  Transdifferentiation challenges our 
preconceived ideas about the nature of the differentiated state. It was generally accepted that the 
terminally differentiated state was fixed, but it is now clear that differentiation can sometimes be 
reversed or altered (Eberhard et al., 2010; Shen and Tosh, 2010; Slack, 1986; Slack and Tosh, 2001; 
Tosh and Slack, 2002). Transdifferentiation is a subset of a wider class of cell type interconversions 
referred to as metaplasias. Examples of transdifferentiation have been documented during 
development (e.g. in the epithelial cell switch from stratified squamous to columnar during 
oesophagus development and from pseudostratified to squamous during the female reproductive 
system development (Cunha, 1976) (Yu et al., 2005) and in the adult (e.g. the appearance of 
hepatocyte in the pancreas) (reviewed by Tosh and Slack, 2002) 
Cells that have the potential to interconvert by transdifferentiation generally arise from adjacent 
regions in the developing embryo (Slack and Tosh, 2001; Tosh and Slack, 2002). For example, the 
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liver and pancreas arise from adjacent regions of the developing endoderm and are able to 
interconvert in later life (Shen et al., 2000). The conversion of one cellular phenotype to another may 
either occur through a process of dedifferentiation and then redifferentiation or directly without an 
intermediate stage of dedifferentiation. The change in cell fate may be brought about by changing the 
local microenvironment (e.g. through the alteration of external factors) which causes a change in the 
expression of key (master switch genes). Master switch genes can determine which part of the body 
is formed by each region of the embryo. In normal development, particular combinations of these 
genes are activated in each region through the action of inducing signals. Each combination encodes 
a particular state of developmental commitment. The protein products of the homeotic genes are 
transcription factors, and their function is to regulate the next level of genes in the hierarchy, which 
eventually leads to individual tissue types. Transdifferentiation can therefore be brought about by 
introducing key master switch genes into cells.  
1.5.2 Transdifferentiation of pancreas to liver 
The appearance of hepatocytes in the pancreas is one well-documented example of 
transdifferentiation. Hepatocytes appear in the pancreas of hamsters or rats in response to various 
experimental treatments - for example, treatment of rats with a copper-deficient diet (Rao et al., 1988) 
(Rao et al., 1989), or after transplantation of pancreatic epithelial cells (Dabeva et al., 1997), and in 
transgenic mice that overexpress keratinocyte growth factor in the pancreatic islets (Krakowski et al., 
1999). The reverse transdifferentiation (liver to pancreatic exocrine cell) is induced in the livers of 
rats after treatment with polychlorinated biphenyls (Rao et al., 1986). This ability to interconvert 
presumably reflects the close developmental relationship between the pancreas and liver: they both 
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arise from the foregut endoderm (Zaret and Grompe, 2008). Their development is controlled by 
signals from adjacent structures of ectodermal and mesodermal origin, the notochord and aorta 
(reviewed by (Wells and Melton, 1999)). I will now review in more detail the models for the 
conversion of pancreatic cells to hepatocytes. The liver, lungs, and ventral pancreas derive from the 
ventral foregut adjacent to cardiac mesoderm and in opposition to the notochord. Liver specification 
from ventral foregut by cues from adjacent cardiac mesoderm has been shown in chick (Le Douarin, 
1968) and mouse (Gualdi et al., 1996). The pancreas develops from the dorsal and ventral domain of 
the foregut. The interaction of endoderm with notochord and other transcription factors including 
FGF2, activin--B which can repress endodermal expressed sonic hedgehog (shh) and induction of 
Pdx1 are necessary for proper dorsal pancreas formation and for expression of pancreatic genes 
(Hebrok et al., 1998). Retinoic acid (RA) however may play a role in ventral pancreatic development 
(Wells and Melton, 1999). The ventral component of the pancreas derives from the endoderm that is 
immediately adjacent and lateral to presumptive hepatic endoderm. Although communication 
between liver and ventral pancreas has not been characterized, it is possible that interaction between 
these adjacent structures plays a role in subsequent morphogenesis.  
Transdifferentiation of pancreatic cells to hepatocytes has been established in both in vivo and in 
vitro models. In vivo studies have been based on treatment with carcinogens or feeding rodents a 
modified diet. One of the most reliable methods for inducing hepatocytes in the rat pancreas is the 
copper-depletion-repletion protocol (Rao et al.1988).  A highly reproducible in vivo model in which 
hepatocytes are induced in the pancreas of adult rats maintained on copper-deficient diet containing a 
relatively non-toxic copper-chelating agent for 7-9 weeks was described by Rao et al, 1988. This 
dietary manipulation resulted in almost complete loss of pancreatic acinar cells at the end of 
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copper-depletion regimen. Northern blot analysis of total RNA obtained from the pancreas of these 
rats revealed the expression of albumin mRNA. Albumin protein was also demonstrated in these 
pancreatic hepatocytes by immunofluorescence. In hamsters, treatment with peroxisomal 
proliferators ciprofibrate, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Rao et al. 1988) or 
N-nitrosobis(2-oxopropyl)amine (BOP) (Scarpelli and Rao, 1981) all induce the appearance of 
hepatocytes in the pancreas. Moreover, a study of hepatocellular carcinoma in the pancreas has 
revealed that hepatic differentiation may arise from any of the three pancreatic cells (endocrine, 
acinar and ductal cells) when investigating human cases (Paner et al., 2002). Keratinocyte growth 
factor (KGF) under the control of insulin promoter can also induce hepatocytes in pancreas 
(Krakowski et al., 1999). Cadmium, a toxin heavy metal, can also induce hepatocytic 
transdifferentiation in rat pancreas (Waalkes et al., 1992). Dabeva et al. (1997) demonstrated that 
epithelial progenitor cells from the pancreas differentiate into hepatocytes and express liver-specific 
proteins when transplanted into the liver (Dabeva et al., 1997). After transplanting genetically 
lacZ-labelled pancreatic duct epithelial cells (previously embedded into collagen matrix) into 
isogenic Fischer-344 rats, Chen et al. (1995) found that ductal pancreatic cells resembled hepatocytes 
in different degrees of differentiation (Chen et al., 1995). Less than 5% of lacZ-labelled cells formed 
ductular structures. The hepatocyte-like cells from the subcutaneous implantation site expressed 
mixed phenotypes of both hepatocyte and ductal cell, including the expression of -fetoprotein, 
tyrosine amino-transferase, gamma-glutamyl transpeptidase, carbonic anhydrase II, and cytokeratin 
19. In contrast, the hepatocyte-like cells colonizing the mesentery showed the phenotype of mature 
hepatocytes, including abundant glycogen storage and a lack of -fetoprotein and carbonic 
anhydrase II expression. Neither acinar cell nor endocrine differentiation was seen (Chen et al, 
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1995). These findings demonstrate that pancreatic ductal cells can be the progenitor cell for 
transdifferentiated hepatocytes. 
Two in vitro models have been developed for converting pancreatic cells to hepatocytes, the 
pancreatic amphicrine call line AR42J-B13 (Shen et al. 2000) and cultured mouse embryonic 
pancreas (Percival and Slack, 1999). These models allow the close observation of the cells during 
transdifferentiation and the ability to trace the cell lineage during their conversion to a hepatic fate. 
The AR42J cells are derived from rat pancreatic tumour (Longnecker, 1994). This cell line probably 
represents a progenitor population that under certain circumstances may generate other cell 
pancreatic cell types. AR42J cells can be converted to endocrine producing insulin cells after 
treatment with activin A and -cellulin (Mashima et al., 1996). AR42J-B13 (B13) cells, a subclone 
derived from the parent AR42J cell line, were induced to form insulin-producing cells after treatment 
with glucagon-like peptide-1 (GLP-1) can generate glucagon secreting -cells (Zhou et al., 1999). 
Shen et al. (2000) have shown that culturing pancreatic B13 cells with the synthetic glucocorticoid 
dexamethasone (Dex) for 2 weeks can induce the transdifferentiation into hepatocytes. The nascent 
hepatocytes loose expression of the pancreatic marker amylase and start to express hepatocyte 
markers such as glucose-6-phosphatase, transferrin (TFN) and albumin. The change in gene 
expression is accompanied by a change in the morphology of the cells.  Indeed following Dex 
treatment, the B13 cells enlarge and flatten onto the substratum. More recently, Lardon et al. (2004) 
demonstrated that treating with Dex can induce adult rat pancreatic acinar calls maintained in culture 
to convert to hepatocyte-like cells (Lardon et al., 2004).  
The glucocorticoid receptor is a ligand activated transcriptional regulator (Glass and Rosenfeld, 2000) 
that acts to induce hepatic transdifferentiation as addition of RU486 to the cultures inhibits the 
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Dex-induced transdifferentiation of B13 cells to hepatocyte-like cells (Shen et al. 2000). Our lab has 
also identified the molecular basis of the switch, which involves induction of the transcription factor 
CCAAT/enhancer-binding protein (C/EBP)β. Transfection of C/EBPβ into AR42J-B13 cells induced 
transdifferentiation, whereas introduction of the dominant-negative form of C/EBPβ (termed 
liver-inhibitory protein or LIP) inhibited the transdifferentiation. Further evidence for a role for 
C/EBPβ in liver development is indicated by the fact that this factor is bound to the albumin 
enhancer in embryonic hepatocytes at embryonic day 12.5 (Bossard et al., 1997). The function of 
C/EBPβ (and the C/EBP family in general) in liver development awaits further clarification as the 
family shows a certain degree of redundancy. Messenger RNAs of C/EBP, C/EBP, and C/EBP 
are expressed by mature hepatocytes in primary cell culture from young adult rats (Borlak et al., 
2002; Borlak and Thum, 2001). These results are consistent with the theory that variations in C/EBP 
expression and function help regulate hepatocyte terminal differentiation (Diehl et al., 1994). In liver 
and intestine C/EBP mRNA expression is coordinately induced just prior to birth (Birkenmeier et 
al., 1989). The role of C/EBP in the developmental expression of a subset of genes governing 
essential metabolic processes had been elucidated with a mutant mouse model that lacks C/EBP. 
The mutation resulted in the failure of the liver and white and brown adipose tissue to develop 
normal metabolic functions in the perinatal period, including hepatic glycogen synthesis and 
gluconeogenesis and the synthesis and deposition of triglyceride in adipose tissue (Tosh et al., 1996). 
Both C/EBP and C/EBPcan transactivate hepatocyte growth factor (HGF). Partial hepatectomy, 
which is known to activate HGF gene expression in the liver, increased C/EBP (especially C/EBP) 
binding activity to this region of the HGF promoter (Jiang and Zarnegar, 1997). The importance of 
the role of both C/EBP and  in hepatocyte differentiation has also been described previously 
(Diehl et al., 1994). 
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Shen et al (2003) showed that when treating mouse embryonic pancreatic cultures with Dex, the 
transcription actor C/EBB is induced in the epithelium and Pdx-1 is reduced (Shen et al., 2003). 
Burke et al (2006) demonstrated in B13 cells, the induction of C/EBP mRNA after only 8 hours of 
treatment with Dex (Burke et al., 2006a). The induction of C/EBP was followed by the 
up-regulation of other liver-enriched transcription factors, including C/EBP, Hepatocyte Nuclear 
Factor 4  (HNF4) and retinoid X receptor  (RXR). Unlike C/EBP (which revealed a strong 
nuclear staining), C/EBP nuclear expression was weaker and restricted to more mature cells. It has 
been shown that during the transdifferentiation of B13 cells to hepatocytes, HNF4 accumulates in 
the nuclei at a stage following induction of C/EBP suggesting that HNF4 may be downstream of 
C/EBP (Shen et al. 2000). HNF4 is a protein that is abundant in both adult and fetal liver as well 
as the intestine (reviewed by Shen et al. 2003). Several studies have shown the importance of 
HNF4 in regulation of liver differentiation and regeneration (Li et al., 2000; Nagy et al., 1994). A 
knockout study in the fetal livers of mice revealed that as a consequence of HNF4 removal, some 
genes essential for liver function are absent e.g. HNF1 and the pregnane X receptor (PXR) (Li et al., 
2000). The retinoid X receptor  (RXR) is involved in the regulation of hepatic metabolism. RXR 
regulates cholesterol, fatty acid, bile acid, steroid and xenobiotic metabolism (Wan et al., 2000). 
Burke et al. (2006) reported that after 9 days of treating B13 cells with Dex, RXR localizes to 
nucleus of the hepatocytes suggesting prolonged Dex-treatment induces a mature liver phenotype. 
Although transfection of C/EBPcaused a similar hepatic transdifferentiation programme to 
treatment of Dex, it did not cause the same degree of morphological flattening suggesting that 




The question arises whether the hepatocytes induced from pancreatic B13 cells are bone fide liver 
cells. The hepatocytes express liver genes involved in phase I and II detoxification pathways, 
ammonia detoxification and glucose metabolism. In addition, the ability of the hepatocytes to 
respond to xenobiotics was tested (Burke and Tosh 2006; Tosh et al. 2002). The hepatocytes were 
found to express significantly higher levels of detoxifying enzyme catalase when treated with the 
peroxisomal proliferator ciprofibrate in comparison to B13 cells treated with Dex alone (Burke et al. 
2006). The hepatocytes also possess the ability to replicate hepatotropic hepatitis B virus (Wang et 
al., 2005). Furthermore, the hepatic phenotype of the cells is stable even after 14 days of Dex 
withdrawal with some of the hepatocytes still expressing liver markers such as TFN or albumin 
following Dex removal (Tosh et al. 2002). 
1.5.3 The Wnt pathway and hepatic transdifferentiation of 
pancreatic cells 
In 2010, Wright and colleagues investigated the role of the Wnt signalling pathway in the 
transdifferentiation of pancreatic B13 cells to hepatocytes (Wallace et al., 2010).  The authors 
suggested that transient suppression of Wnt signalling is pivotal to the glucocorticoid-dependent 
transdifferentiation of B13 cells. They found that glucocorticoid treatment would result in a transient 
loss of constitutive WNT3a expression, phosphorylation and depletion of -catenin, loss of -catenin 
nuclear localisation, and significant reduction in TCF/LEF transcriptional activity before overt 
changes in phenotype into hepatocyte-like cells (the authors referred to the hepatocytes as B-13/H 
cells). A return to higher TCF/LEF transcriptional activity correlated with the re-expression of 
WNT3a in B-13/H cells. -catenin knockdown alone substituted for and enhanced 
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glucocorticoid-dependent transdifferentiation. Similarly, overexpression of a mutant-catenin 
(pt-X-cat) protein that blocked glucocorticoid-dependent suppression of TCF/LEF activity resulted 
in inhibition of transdifferentiation. A small-molecule activator of TCF/LEF transcription factors 
blocked glucocorticoid-dependent effects, as observed with pt-X-cat expression. Quercetin (a 
TCF/LEF inhibitor) did not promote transdifferentiation into B-13/H cells, but did potentiate 
glucocorticoid-mediated transdifferentiation. Later a serine/threonine protein kinase (serum and 
glucocorticoid regulated kinase 1 (SGK1) which was markedly induced in the B-13/H cells was 
shown to direct phosphorylate -catenin (Wallace et al, 2010). These data demonstrate that the 
transdifferentiation of B13 cells into hepatocyte-like cells in response to glucocorticoid may be 
dependent on the repression of constitutively active WNT signalling.   
1.6 Aims 
To determine the expression of Wnt ligands, receptors and co-receptors in 
developing mouse liver. 
To date, the expression of members of the Wnt signalling family including ligands, receptors and 
effectors are not well characterised during normal mouse development. Indeed the data so far is 
limited to RT-PCR results (Bi et al., 2009). The main concerns with the RT-PCR data are that it 
reflects expression at the whole organ rather than at the cellular level and the technique suffers from 
relatively poor sensitivity. Here we aim to determine the expression of members of the Wnt 
signalling family by a combination of in situ hybridization, immunostaining and western blotting to 
reveal the comprehensive expression pattern during mouse liver development. 
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To determine the role of the Wnt/-catenin pathway in liver development 
While we know quite a lot about the role of the Wnt/-catenin signalling pathway in liver 
development and in the maintenance of zonation in the adult liver we do not know whether the 
Wnt/-catenin pathway is also critical for the induction of metabolic zonation in the developing 
mouse liver. To address this shortfall, we will determine the effects of -catenin activation and 
deletion in mouse liver development (and more specifically metabolic zonation) by conditional 
deletion of either Apc or -catenin.  
To test whether exogenous application of Wnt/-catenin components is able to 
promote a periportal or a perivenous phenotype in cultured mouse embryonic 
liver buds. 
Previous studies have shown that the Wnt/-catenin pathway controls the perivenous and periportal 
programs of gene expression (Benhamouche et al, 2006; Burke et al, 2009).  Our goal is to use our 
understanding of the role of the Wnt/-catenin pathway to promote a periportal or perivenous-like 
phenotype in cultures of embryonic mouse liver. 
To dissect the molecular mechanisms underlying glucocorticoid-induced 
transdifferentiation of pancreatic cells to hepatocytes 
An in vitro model of transdifferentiation has been developed for converting pancreatic cells to 
hepatocytes based on the addition of the synthetic glucocorticoid Dexamethasone to the pancreatic 
cell line AR42J-B13 (B13) (Shen et al. 2000). While the induction of C/EBP is known to be an 
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early event in the Dex-induced transdifferentiation, the role of the liver-enriched transcription factor 














 mice were designed as previously described (Shibata, 1997). To investigate the 
phenotype of conditional deletion of Apc and -catenin, mice bearing a loxP-flanked Apc or 
-catenin allele were crossed onto a novel inducible cre transgenic background, which uses the 
Cyp1A promoter to deliver inducible cre expression in the liver (Sansom et al, 2004). In this 
transgenic line (Ahcre), cre expression is inducible from a cytochrome P450 promoter element that is 
transcriptionally up-regulated in response to lipophilic xenobiotics such as -napthoflavone. 
Extensive recombination showed in liver, intestine, pancreas, gallbladder, esophagus, and stomach in 
response to -napthoflavone treatment (Sansom et al, 2004). The Ahcre model provides a simple 
route for introducing specific gene mutations into many of the epithelia of the gastrointestinal tract of 
the mouse. It has been used to show that -catenin is required for the maintenance of intestinal cell 
proliferation and is implicated in goblet cell differentiation and enterocyte-matrix attachment 
(Ireland et al, 2004). Outbred male mice from 6 to 12 weeks of age were segregated for the C57BJ 
and S129 genomes. The loxP flanked alleles used was AhCre. Timed pregnancies were performed 
and the age of the embryos was determined by the day a vaginal plug was detected, which was 
assigned as day 0.5 (E0.5). To induce recombination, pregnant mice were given intraperitoneal 
injections of -napthoflavone (-NF) (80 mg/kg) at the times indicated. Mice were humanely killed 
by a Schedule 1 procedure. All experiments were performed under the UK Home Office guidelines. 
2.1.2 General chemicals, fixatives and buffers 
58 
 
Table 2-1 List if reagents used for immunostaining 
Chemical, fixatives and 
buffer 
Components Supplier 
Acetone:Methanol (Ac:Me) 1 volume acetone: 1 volume 
methanol 
Fisher Scientific 
Blocking buffer (BB) 2% (v/v) BB made in phosphate 
buffered saline (PBS) from 10% 
BB. A 10% (w/v) working stock 
of blocking powder was prepared 
by dissolving the BB in maleic 
acid buffer [100mM Maleic acid, 
150 mM NaCl, pH7.5] 
Roche 
Bovine serum albumin (BSA) 1% (w/v) of BSA in PBS Sigma, UK 
Citrate buffer 1% (v/v) Citrate buffer Lab vision 
Ethylene-diaminetetraacetic 
acid (EDTA) 
1%(v/v) EDTA buffer Lab vision 
Gel mount  Biomedia 
Paraformaldehyde (PFA) 4% (w/v) PFA in PBS, pH 7.4 Fisher Scientific 
PBS 0.95% (w/v) PBS Autogen Bioclear 




 BBC Biochemical, 
 
2.1.3 Cell culture medium, reagents and exogenous factors 
Table 2-2 Composition of medium used for cell culture 
Culture medium Supplier 
Dulbecco’s Modified Eagle’s Medium (DMEM)  Sigma, UK 
Basel Medium Essential (BME) Sigma, UK 
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Minimum Essential Medium Eagle Sigma, UK 
Reagent Final concentration Supplier 
Fetal Bovine Serum (FBS) 10 % (v/v) Sigma, UK 
Gentamycin 20g/ml Gibco Invitrogen 
L-Glutamine 2mM Sigma, UK 
Penicillin-streptomycin 100 units/ml, 100g/ml Sigma, UK 
Trypsin- EDTA  Gibco Invitrogen 
Dexamethasone (Dex) 1M final (stock solution of 
1mM of Dex made up in 100% 
Ethanol) 
Sigma, UK 
Quercetin  Sigma, UK 
Insulin-Transferrin-Selenium 
(ITS) 
 Sigma, UK 
 
2.1.4 Markers for immunofluorescence cell staining 
Table 2-3 List of primary antibodies used for immunofluorescence cell staining 
Primary 
antibodies 
Species Fixation Dilution Antigen 
retrieval 
Supplier 
Anti-amylase Rabbit PFA 1:100  Sigma, UK 
Anti-Albumin Rabbit PFA 1:200  Abcam 
Anti-a-fetoprotein 
(AFP) 
Rabbit PFA 1:200  Abcam 




Rabbit PFA 1:200  Abcam 
Anti-CPS Rabbit Methanol 1:200 EDTA Abcam 
Anti-Glutamine 
synthetase (GS) 
Mouse PFA 1:300 Citrate BD 
Tansduction 




region Y)-box 9 
(Sox9) 
 
Table 2-4 List of secondary antibodies used for immunofluorescence cell staining 
Secondary 
antibodies 
Species Conjugate Dilution Supplier 




Anti-mouse Horse Texas-red 1:200 Vector 
Anti-rabbit Goat FITC 1:200 Vector 
Anti-rabbit Goat Texas-red 1:200 Vecor 
2.1.5 Primary and secondary antibodies used for staining tissue 
sections 
Table 2-5 List of primary antibodies used for immunohistochemistry staining 
Primary 
antibodies 





GS Mouse PFA or 
Formalin 
1:200 Citrate BD 
Transduction 
CPS Rabbit Methanol or 
Formalin 
1:200 EDTA Abcam 
-catenin Mouse PFA or 
Formalin 
1:50 EDTA BD 
Transduction 
Sox9 Rabbit PFA or 
Formalin 




2.1.6 Western blotting materials, reagents, primary and 
secondary antibodies 
Table 2-6 List of chemicals used for western blotting 
Materials and regents Components and suppliers 
PBS-Tween (PBST) 0.1%(v/v) Tween-20 (Sigma, UK) in PBS 
Blocking solution 5% (w/v) Marvel (non-fat milk) in PBST 
Enhanced chemiluminescence (ECL) Amersham 
Extra thick filter paper Bio-Rad 
Lysis buffer 0.5M Tris-HCl (Fisher Scientific) pH6.8 
Precision Plus Protein Rainbow Standard 
Ladder 
Bio-Rad 
Protease inhibitor cocktail (Catalog number 
P8340), Components including AEBSF, 
104mM; Aprotinin, 80μM; Bestatin, 4mM; 




Bio-Rad Protein Assay Dye Reagent 
Concentrate (Catalog number 500-0006) 
Bio-Rad, UK 
Running buffer 25mM(w/v) Tris (Fisher), 192mM(w/v) Glycine 
(Fisher), 0.1% Sodium dodecyl sulphate (SDS) 
(Sigma, UK) 
2x Sample buffer  0.125M Tris-HCl pH6.8, 4% SDS, 20% 
Glycerol, 0.02% Bromophenol blue pH6.8, 
0.2M Dithiothreitol (DTT) (Sigma, UK) 
Transfer buffer 25mM Tris, 193mM Glycine, 20% Methanol 





Table 2-7 List of primary antibodies used for western blotting 
Primary 
antibodies 
Species Dilution Supplier Secondary antibodies 
Dilution Species/Conjugate Supplier 




CPS Rabbit 1:2000 Abcam 1:2000 Goat-HRP Vector 
GS Mouse 1:2000 Transduction 1:2000 Goat-HRP Vector 
GAPDH Mouse 1:10000 Chemicon 1:2000 Goat-HRP Vector 
LaminB1 Goat 1:1000 Santa Cruz 1:2000 Donkey-HRP Santa Cruz 
All antibodies were diluted in 3% marvel in PBST. 
2.1.7 RNA extraction, reverse transcription (RT) and 
polymerase chain reaction (PCR) reagents and experimental 
conditions 
Table 2-8 List of chemicals used for RNA extraction and RT-PCR 
Reagent Supplier 
RNA extraction 
Chloroform Fisher Scientific 
75% Ethanol Fisher Scientific 
Isopropanol Fisher Scientific 
Tri reagent  Sigma, UK 
RT 
10mM dNTP Mix Invitrogen 
0.1M DTT Invitrogen 
Oligo(dT)12-18 oligonucleotides Invitrogen 
SuperScript ll Reverse Transcriptase 10000U Invitrogen 




100 bp DNA ladder Geneflow 
1kb DNA ladder Geneflow 





Table 2-9 List of PCR primers 
Primers Forward Reverse 
Rat-Albumin GCCCTACCCACAAAGCCTCAG AGCCCCTTCATATCACAGAGC 
A 
Rat-AFP AACAAGTATGGATTCTCAGG ATTGATGCTCTCTTTGTCTG 
Rat--actin TCCGTAAAGACCTCTATGCC AAAGCCATGCCAAATGTCTC 
Rat-CPS CGTCCAAGATTCCTTGGTGT ATGGAAGAGAGGCTGGGATT 
Rat-CK7 ACTTGCTGGCACCTCTGAGT GCTGCTCTTGGCTGACTTCT 
Rat-CK19 GAGCTGGAGGTGAAGATTCG TCAAACTTGGTCCGGAAGTC 
Rat-Cx43 TCTTCATGCTGGTGGTGTC TAACCAGCTTGTACCCAGG 
Rat-Sox9 CAAGACTCTGGGCAAGCTCTG TCTGCTTGCCCATTCTTCAC 




Mouse-Glt1 ATGTCCACGACCATCATTGC ACCTCGTCGTTCTTCTTCCC 
Mouse-Arginase I GGTTCTGGGAGGCCTATCTT TTATGGTTACCCTCCCGTTG 
Mouse-ASS TGGATACAGTGGCGAACAAA AGCAGGGACCATCCTTTACC 
Mouse-ASL CAGGTTGAGAGCCACTCCTT3 CAAGCTCACCTTTTGCTGGT 
Mouse-RNase4 GAACGGCCAGATGAACTGTCA CTGGTTCTTGCCCTGTATCTA 
Mouse-RHBG GTGTGGGCTTTACCTTCCTCG CGCAGAAGTCAGCGTTGAT 
Mouse-PEPCK TGGCTACGTCCCTAAGGAA GGTCCTCCAGATACTTGTCGA 
Mouse-GS TTTATCTTGCATCGGGTGTG TTGATGTTGGAGGTTTCGTG 









Mouse--catenin GCAACCCTGAGGAAGAAGAT TTAGCTCCTTCCTGAGGAG 




Mouse-Connexin43 GAGGGAAGTACCCAACAGCA CCC AGGAGCAGGATTCTGA 
Mouse-Sox9 CGCCTTGAAGATAGCATTAGGA CAAGAACAAGCCAGCCGTCA 
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Mouse- Hes1 AGCACAGAAAGTCATCAAAGCC TTCATGCACTCGCTGAAGCC 
Mouse- Hey1 GCCGACGAGACCGAATCAAT GCTGGGATGCGTAGTTGTTG 
Mouse-manic fringe CGTGATGTGTATGTGGGCAAG TCAGGGCGCTGCCAGCAG 
 
2.1.8 Adenovirus (Ad) reagents, materials and kits 
Table 2-10 List of adenoviral vectors used for gene transduction 
Adenovirus construct Constructed by Titre (iu/ml) 






















Ad-CMV-LAP Gift from Dr. Hiroshi Sakaue, 
Japan (Schroeder-Gloeckler 















2.1.9 Other instruments 
Table 2-11 List of other general instruments 
Instrument Supplier 
NanoPhotometer Pearl Geneflow, UK 
L-80 ultracentrifuge Beckman, UK 
DMRB microscope Leica, UK 
DMIRB inverted microscope Leica, UK 






2.2.1 Cell culture 
2.2.1.1 Cell culture  
The AR42J-B13 (B13) cell line (provided by Dr. Itaru Kojima, Maebashi Japan) was maintained in 
complete media composed with DMEM supplemented with 10% FBS, 1% penicillin/streptomycin 
and 2% L-glutamine as described previously (Shen et al. 2000). The B13 cells were treated with 
1M Dex every other day. 
2.2.1.2 Cell culture maintenance  
B13 cells were cultured in complete media in 75cm
2
 tissue culture flasks and passaged when cells 
were approximately 90% confluent. To passage the cells the media was removed and 10ml of PBS 
was added to remove excess serum from the cells. The PBS was then decanted off and 3ml of 
Trypsin-EDTA solution was added and the cells incubated at 37℃ in 95% air / 5% CO2 for 3-5min. 
The flask was gently tapped until the cells were dislodged and then the cell suspension was added to 
a 12ml centrifuge tube containing 9ml of complete medium. The supernatant was then removed and 
the cells were resuspended in 1ml of complete medium. Approximately 100l of cell stock was 
inoculated in a new 75cm
2
 tissue culture flask containing 12ml of complete medium and incubated at 




2.2.1.3 Cell storage and revival  
Unused cell stock was spun down at 1000 rpm for 4 min using MSE Mistral 1000 centrifuge. The 
supernatant was decanted off and 1ml of freezing medium (10% Dimethyl sulphoxide (DMSO) in 
FBS) was added to the 12ml centrifuge tube and mixed with the cells. The suspension was then 
transferred to a 2ml cryogenic vial and stored in a -20℃ freezer for 1hr before transferring to -80℃ 
freezer. The next day, vials were transferred to liquid nitrogen.  
2.2.1.4 Inoculation of cells  
Approximately 2l of cell stock was added to 2ml of complete medium and seeded into a 35mm 
tissue culture dish. For immunostaining, the cells were plated into dishes containing sterile glass 
coverslips at a confluence of 10-15%. Cells were allowed to attach for 24hrs at 37℃ in an 
atmosphere of 95% air / 5% CO2.  
2.2.2 Fractionation of liver tissue 
Liver tissue was lysed and homogenized in 500μl of cytosolic extraction buffer (10mM KCl, 20mM 
HEPES, 1mM EDTA, 10% Glycerol, pH7.9). The lysate was rotated at 4°C for 30min at 10 rpm and 
then homogenized by passing through a 27G needle using a 1ml syringe. The nuclear pellet was 
prepared by centrifugation at 3000 x g for 5 min at 4°C. The supernatant (which preserves the 
soluble cytoplasmic contents) was transferred to a freshly labelled eppendorf and the pellet contains 
mitochondria and ER-golgi membrane and intact nuclei. The pellet was then washed twice by 500μl 
of cytosolic extraction buffer and then dissolved in 50μl nuclear extraction buffer (10mM KCl, 
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20mM HEPES, 400mM NaCl, 1mM EDTA, 20% Glycerol, pH7.9) and rotated at 4°C at 10rpm for 
60min. The lysate were then centrifuged again at 16300 x g for 15 min at 4°C and the supernatant 
(which preserves the soluble nuclear extract) was then transferred to a freshly labelled eppendorf and 
stored at -80°C. The recovered insoluble pellet contains cytoskeletal, membrane and 
chromatin-bound proteins. 
2.2.3 Western blotting 
Protein extracts were prepared from liver samples by a cycle of rapid freeze–thawing in lysis buffer 
(0.5 mol/l Tris-HCl [pH.6.8] containing a 1:100 dilution of protease inhibitor cocktail (Sigma, UK). 
Samples were centrifuged at 14,000 rpm for 10 min at 4°C to remove cellular debris and quantified 
using the Bio-Rad (Hercules, California) protein assay reagent. Protein extracts were denatured by 
mixing with a 2 x SDS-PAGE loading buffer containing 0.125 mol/l Tris-HCl pH 6.8, 4% SDS, 20%, 
glycerol, 0.2 mol/l DTT, 0.02% bromophenol blue and heated to 100°C for 5 min. We separated 
10g of protein on a 5% or 10% Criterion precast Tris-HCl polyacrylamide gel (Bio-Rad) and then 
transferred the protein onto a BioTraceNT nitrocellulose membrane (Pall Corporation, Pensacola, 
Fla). The membrane was blocked using 5% (w/v) Marvel in 0.1% (v/v) PBS-Tween and 
subsequently probed with primary antibody.  Briefly, antibodies were obtained and diluted as 
follows: anti-mouse -catenin (1:5000, Transduction), anti-mouse GS (1:15000, Transduction), 
anti-rabbit CPS (1:15000, Abcam) (Table 2-7). Anti-mouse glyceraldehyde- 3-phosphate 
dehydrogenase (GAPDH; 1:2000; Ambion) and anti-goat-Lamin B1 (1:2000, Santa Cruz) were used 
as loading control. Secondary antibodies were obtained and diluted as follows: peroxidase labeled 
anti-rabbit or anti-mouse both at 1:2000 (Amersham Biosciences, Bucks, UK). The signal was 
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detected with the ECL TM Western blotting analysis system (Amersham) and developed on 
Hyperfilm (Amersham). Experiments were repeated at least 3 times and typical results are shown. 
2.2.4 Semi-quantitative RT-PCR 
Total RNA was isolated from the cells or tissues using TRI reagent (Sigma, Poole, UK). Digestion 
with RQ1 RNase-free DNase (Promega, Southampton, UK) was performed to eliminate any 
contaminating genomic DNA. The concentration of extracted RNA was measured on a Beckman 
Spectrophotometer. Messenger RNA was isolated from total RNA by using SuperScript First-Strand 
Synthesis System for RT-PCR (Invitrogen Life Technologies). Messenger RNA (mRNA) was first 
isolated by incubation of Oligo(dT)12–18 oligonucleotides from 2g extracted total RNA; 
complementary DNA (cDNA) was prepared by SuperScript II reverse transcriptase treatment. cDNA 
samples were incubated with 2 units of RNase H at 37
o
C for 20 min to remove the RNA–cDNA 
hybridised residues. Polymerase chain reactions containing the mixture of the same concentration of 
cDNA, 1.1 X ReddyMix™ PCR Master Mix (ABgene, Surrey, UK) and 50 ng primers (listed in 
Table 2-9.) were processed in a DNA thermal cycler using the following conditions: denaturation at 
94°C for 1 min, amplification at 56°C for 1 min and elongation at 72°C for 1 min for the indicated 
cycles. The samples were analyzed by electrophoresis using a 1.0% agarose gel and a 1 kb ladder 
(Invitrogen Life Technologies). Experiments were repeated at least 3 times and typical results are 
shown. 
2.2.5 Fluorescence microscopy and image processing 
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For immunofluorescent staining, cells were cultured on noncoated glass coverslips, rinsed with PBS, 
fixed with 4% paraformaldehyde (PFA) in PBS for 30 min or ice cold Acetone/Methanol (1:1) for 5 
min. For PFA fixed cells, cells were then permeabilised with 0.1% (vol/vol) Triton X-100 in PBS for 
30 min, and incubated in 2% blocking buffer (Roche, East Sussex, UK), then incubated sequentially 
with primary antibodies for overnight at 4℃ and secondary antibodies for 2 hours at room 
temperature. After incubation of secondary antibodies, cells were washed 3 times with PBS buffer 
and counterstained with 4’6’-diamidinp-2-phenylindole (0.1g/ml DAPI), and then mounted in 
mounting medium. Alternatively, for staining of liver buds cultures, the buds were fixed with 
MEMFA (10% formaldehyde, 0.1M Mops, pH7.4, EGTA 2mM, MgSO4 1mM) for 20 min at room 
temperature. They were then washed in PBS and stored in PBS at 4℃ for up to a few days. Prior to 
immunostaining, the cultures were treated with 1% Triton X-100 in PBS and then blocked as 
described above. The details and working dilution of antibodies has been listed in Table 2-3 and 
Table2-4. 
Specimens were observed using Leica DMRB fluorescent microscope. Images were then collated 
into figures in Adobe Photoshop 7.0. Experiments were repeated at least 3 times and typical results 
are shown.  
2.2.6 In situ hybridization 
2.2.6.1 Mice and isolation of embryos 
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Animal husbandry and embryo isolation were carried out in accordance with Home Office 
regulations. Stage specific embryos were isolated from timed matings of CD1 mice, based on the 




2.2.6.2 RNA probe synthesis  
Digoxigenin (DIG)-labelled antisense and sense riboprobes were transcribed via the T7/SP6 RNA 
transcription system (Roche Diagnostics) according to the manufacturer’s guidelines. The RNA 
probe sizes were as described as Table 3. In situ hybridization experiments were performed at least 
six times. For each experiment, at least four embryos from each developmental stage were used. 
Typical results are shown. 
Table 2-12. Riboprobes for in situ hybridization 
RNA probe Corresponding 
cDNA region (bp) 
Length (bp) 
Fzd1 3151-3560 409 
Fzd2 902-1300 398 
Lrp5 600-1120 520 
Wnt4 269-462 193 
Wnt5a 820-1318 498 
Wnt5b 1534-1774 240 
Wnt9b 535-735 200 





2.2.6.3 Tissue preparation 
Embryos were dissected and washed several times in sterile PBS. Following fixation in 4% PFA at 
4ºC for overnight all embryos were washed three times in sterile PBS and processed for 
cryosectioning. The embryos were then preserved overnight in 30% sucrose in PBS, embedded in 
Optimal Cutting Temperature compound (OCT) media and stored at -80ºC. 
2.2.6.4 In situ hybridization on sections 
For in situ hybridization, cryosections (14m) were obtained using a Leica CM1850 cryostat. 
Sections were fixed for 10min in 4% PFA and then washed 3 times in PBS for 3min each. The 
sections were then treated with 1 g/ml proteinase K in 50 mM Tris pH 7.5, 5mM EDTA for 2-6 min 
according to the embryonic stage (2min for E10.5, 3min for E11.5, 4min for E12.5, 5min for E13.5 
and 6min for E14.5-E18.5). Following proteinase K treatment, the sections were fixed again in 4% 
PFA for 10 min and then washed 3 min in PBS. The sections were washed a total of three times in 
PBS. Sections were acetylated in a buffer containing 1.36% triethanolamine, 0.18% HCl and 0.25% 
acetic anhydride for 10min and washed three times in PBS for 5 min each. Prehybridization was 
carried out in a 5 x saline sodium citrate (SSC) buffer humidified chamber at room temperature for 
2hrs in hybridization buffer containing 50% formamide, 5 x SSC (pH4.5), 50g/ml yeast RNA, 1% 
SDS and 50g/ml heparin. Probes were diluted to 0.5g/ml in hybridization buffer, heated to 80ºC 
for 5min and cooled for 5 min at room temperature. Hybridization was carried out overnight at 72ºC 
in a 50% formamide/5 x SSC humidified chamber. Posthybridization, the sections were washed as 
follows; 3 hours at 72ºC in 0.2x SSC for 3 hours, three times for 5 min each in 0.2 x SSC at room 
temperature and once in a solution (which we refer to as solution 1) containing 0.1M Tris (pH7.5), 
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0.15M NaCl and 0.24mg/ml levamisole for 5 min. Sections were blocked for 1hr in blocking solution 
containing 2% heat inactivated fetal calf serum and 2 % blocking reagent (Roche) in maleic acid 
buffer (100mM maleic acid and 150mM NaCl, pH7.5) and incubated overnight with an anti-DIG 
alkaline phosphatase antibody (1:5000 dilution in blocking solution) at 4ºC in a humidified chamber. 
Excess antibody was removed by washing three times for 5 min each in solution 1 and sections 
equilibrated by washing three times 10 min each in a solution (solution 2) containing 0.1M Tris 
pH9.5, 0.1M NaCl, 50mM MgCl2, 1% Tween-20. Sections were then incubated with nitro-blue 
tetrazolium and 5-bromo-4-chloro-3'-indolyphosphate (NBT/BCIP) substrate (diluted to 20 l/ml in 
solution 2) for 6hrs to 3 days. The reaction was stopped with 50mM Tris pH8.0, 5mM EDTA and the 
sections mounted in gel mount prior to photography. Experiments were repeated at least 6 times and 
typical results are shown. 
2.2.7 Immunohistochemistry of mouse liver 
2.2.7.1 Tissue Fixation, Embedding, and Processing 
Embryonic livers were fixed by incubation overnight in 4% paraformaldehyde or 10% formalin 
(Sigma, St Louis, Mo) at 4°C depending on the antibody to be used. After fixation, tissue samples 
were processed sequentially through the following: PBS, NaCl, 50% ethanol, 70% ethanol, 90% 
ethanal, 100% ethanol, 100% ethanol, Histoclear, wax, wax and wax for one hour each in the Leica 
TP 1020 tissue processor. The tissue was embedded in paraffin wax at a Leica EG 1160 embedding 
station and sectioned using a Leica RM 2155 microtome into 4m ribbons that were mounted on 
Fisherbrand microscope slides.  
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2.2.7.2 Immunohistochemical Analysis of Embryonic Mouse Liver 
Samples were dehydrated through an increasing ethanol series, embedded in paraffin wax and 
sectioned at 5m. Immunostaining for GS, CPS, Sox9 and phospho-histone3 was carried out as 
follows. Sections were dewaxed and rehydrated through a decreasing series of ethanol (100%, 100%, 
95%, 90%, 70%, and 50%). Sections were rinsed in distilled water (dH2O), washed twice in 
phosphate-buffered saline (PBS) for 5min each and permeabilized with 0.5% triton X-100 for 30min. 
High temperature antigen retrieval was performed in citrate (for GS) or EDTA (for Sox9 and CPS) 
buffer for 30min at 90°C and sections were allowed to cool to room temperature for 30min. After 
two 5-minute washes in PBS, endogenous peroxidases were quenched with the DAKO Envision 
peroxidase block (Glostrup, Denmark) for 10min. Sections were washed in PBS and blocked for 
30min in 2% blocking buffer Roche (Mannheim, Germany) before addition of the following 
antibodies: anti-mouse GS (1:400; Transduction Laboratories, San Diego, California), anti-rabbit 
CPS (1:100, Abcam), anti-rabbit Sox9 (1:100; Millipore) and anti-rabbit-phosphohistone H3 (1:100, 
Upstate) in 2% blocking buffer overnight at 4°C. Excess primary antibody was removed by washing 
3 times in PBS for 10min each. Sections stained for GS, Sox9 and phosphohistone H3 were 
incubated with the DAKO Envision peroxidase-labeled anti-mouse or rabbit secondary antibody 
polymer for 30min. The DAB substrate-chromogen mixture was added to the sections and allowed to 
develop within 10min. The reaction was terminated in dH2O and the sections counterstained with 
haematoxylin where appropriate. Immunostaining for -catenin (1:50; Transduction Laboratories) 
was carried out as previously described (Sansom et al., 2004). Sections stained for CPS were 
incubated with fluorescence conjugated secondary antibody after washed out excessive primary 
antibodies, Alexa Fluor 546 goat anti-rabbit IgG (Invitrogen) for 60min and then washed 3 times in 
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PBS for 10min each. The slides were then mounted with Mowiol. Specimens were observed using a 
Leica DMRB microscope. Image collection from the Leica was made with a Spot camera and images 
collated into figures in Photoshop. Experiments were repeated at least 3 times and typical results are 
shown. 
2.2.8 Embryonic mouse liver bud dissection 
Embryos were obtained from female CD1 mice (University of Bath, UK) 11.5 days postcoitum. The 
pregnant female mice were killed by cervical dislocation and the uteri were removed from the uterus. 
The uteri were transferred to a 100mm Petri dishes containing ice-cold phosphate buffered saline 
(PBS) where individual embryos were separated using surgical scissors (see Figure 2-1). The 
embryos were removed from their deciduas using fine forceps. The embryos were then transferred to 
a 60mm Petri dishes containing Minimum Essential Medium with Hank’s salt (Sigma) and 
supplemented with 10%FBS, penicillin (100U/ml), streptomycin (100g/ml), 2mM L-glutamine and 
gentamycin (20g/ml). Using a tungsten needle, the liver buds were removed from its location. The 
liver buds were collected for tissue culture in 35mm culture dishes containing Basal Medium 
Essential (BME) medium supplemented with 10%FBS, penicillin (100U/ml), streptomycin 








Figure 2.1 Steps in the dissection of liver bud from E11.5 mouse embryos 
A. Separated uteri in 60mm Petri dish containing PBS.  
B. E11.5 mouse embryo isolated from uteri. 
C. Decapitation and dissect out tail (alone the black lines) and four limbs 
D. Opening up the embryo (alone the dashed line) and removal of the internal viscera 
E. Separation of the liver bud from the stomach 





2.2.9 Embryonic culture of mouse liver buds 
Cultures were set up as described in Burke et al (2010) with minor modification. The liver buds were 
isolated from E11.5 mouse embryos as described above. To set up cultures, the coverslips were 
placed in 35 mm petri plates containing BME medium with Earle’s salt, 20% foetal bovine serum 
and 50ug/ml gentamycin. A plastic cloning ring of 3 mm internal diameter was placed over a 
fibronectin-coated area, and cut pieces of liver were dropped into the centre. To ensure spreading 
during culture, the buds were turned if necessary with fine needle so that the cut surface lay in 
contact with the fibronectin. Cultures were maintained for up to 7 days at 37℃ in 95% air / 5% CO2, 
with a change of medium every day. The cloning ring was removed at the second day of culture.  
2.2.10 Adenoviral infections 
2.2.10.1 Amplification of first-generation adenovirus 
Adenoviral vectors were amplified in Human embryonic kidney (HEK) 293 cells grown in DMEM 
supplemented with 10% gamma irradiated FBS, penicillin (100U/ml), and 2mM L-glutamine. To 
amplify the virus, 3x T225 flasks were seeded with HEK 293 cells. When the cells reached 70% 
confluency, the media was replaced with 35ml of fresh DMEM and different dilutions of viral 
pre-stock (125l, 12.5l and 2l) was added to each flask to ascertain the optimal volume. After 
24hrs the cells should show small signs of cytopathic effect (CPE). A high CPE is not desirable and 
is caused by adding too much virus. After 48hrs the 50% cells should detach from the flask. If no 
effect is seen then the volume of virus added is not enough. The cells infected with optimal virus 
volume were harvested by shaking the flask to detach the remaining cells. The cells were pipetted 
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into 50ml Falcon tubes and centrifuged at 1000rpm for 4min. The supernatant was discarded and the 
pellet resuspended in 1ml of DMEM supplemented with 10% gamma irradiated FBS, penicillin 
(100U/ml), and 2mM L-glutamine. To lyse the cells, the cells were frozen on dry ice and thawed 
rapidly at 37℃ in water bath while shaking vigorously. The freeze/thaw cycle was repeated three 
times to release the virus. The pre-stock was then stored in -80℃. 
2.2.10.2 Further adenovirus amplification and dialysis  
Eight T225 flasks of HEK 293 cells at 70% confluency were infected with the previously determined 
volume of pre-stock. The cells were harvested 2-4 days later and centrifuged at 402 x g for 10min in 
4 x 50ml Falcon tubes. The supernatant was discarded and the pellets were resuspended in 5ml of 
100mM Tris-HCl. The cells were freeze/thawed rapidly four times and centrifuged at 402 x g for 
5min. The supernatant was collected in 10ml syringes to estimate the volume and mixed with 0.6 
volume of CsCl-saturated 100mM Tris-HCl. The virus supernatant was mixed and placed into 
Beckman 342412 centrifuge tubes. The tubes were filled to the neck and sealed so that no air bubbles 
were present. The tubes were then spun at 65000rpm for 24hrs at 22℃ in an ultracentrifuge 
(Beckman Vti90 rotor was used). After the tubes were removed, a white band of virus was visible 
approximately half way down the tube. To collect the virus, the bands were extracted using a 25G 
needle attached to a 2ml syringe inserted just below the band. The collected virus was then 
transferred to a new Beckman centrifuge tube and filled with balance solution (one volume of 
100mM Tris-HCl pH8.0 with 0.6 volume of CsCl-saturated Tris-HCl). The tube was then sealed and 
spun again at 65000rpm overnight at 22℃ in the ultracentrifuge. The virus band was extracted again 
in 0.8-1.1ml and injected into a gamma irradiated Slide-A-Lyzer dialysis cassette (Pierce) with most 
of the air bubbles removed. The cassette was attached to a float and incubated while being stirred in 
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one litre of cold dialysis buffer (10mM Tris-HCl pH7.5 and 1mM MgCl2) for 1hr. The buffer was 
then replaced with fresh buffer and the cassette was left for another hour. The virus was then 
extracted and passed through a 0.22m filter into a Falcon tube. The virus was then aliquoted into 
sterile eppendorf tubes, frozen on dry ice and stored at -80℃.    
2.2.10.3 Rapid titre of adenovirus  
To titre the virus, a 12-well plate was seeded with HEK 293 cells. When the cells were 90% 













100l of each dilution was added to each well with one well left uninfected to as a negative control. 
The infected cells were incubated for 48hrs at 37℃. Later, the cells were fixed with ice-cold 
methanol and incubated at 4℃. After 10min the fixed cells were washed with 3x PBS and blocked 
by adding 1ml of 2% blocking buffer to each well and left for 30min. The mouse anti-hexon primary 
antibody was diluted 1:1000 in 2% blocking buffer and 0.5ml was added to each well after blocking. 
The cells were incubated with antibody for 1hr. The secondary HRP conjugated rat anti-mouse 
antibody was then diluted 1:500 in 2% blocking buffer and 0.5ml was added after washing 3xPBS. 
The cells were left to incubate for 1hr. Later, 3,3'-Diaminobenzidine (DAB) solution was prepared as 
recommended by the manufacturer (Vector Laboratories). The cells were washed again 3xPBS after 
removing the secondary antibody and 0.5ml of the DAB solution was added to each well. Infected 
cells were stained with 2-3min. The cells were viewed under the Stereomicroscope (DTX-10) and 
the reaction stopped by rinsing the cells with water. The cells were counted in 6 fields viewed under 
the 20x objective. The titre was then estimated as follows: average number of infected cells per field 
x573/0.1 x dilution factor.  
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CHAPTER 3 EXPRESSION PROFILING OF 
HEPATOCYTE MARKERS AND WNT 
LIGANDS AND RECEPTORS DURING 





Metabolic zonation in the adult liver has been studied extensively (Gebhardt, 1992). However, the 
molecular mechanism(s) responsible for the induction of zonation during embryonic liver 
development remains less well understood. The detoxification of ammonia is heterogeneously 
distributed across the liver lobule, The liver contains two systems for the detoxification of ammonia 
the urea cycle and glutamine synthetase.  The enzymes of the urea cycle and glutamine synthetase 
have a reciprocal distribution pattern in the liver. In adult liver, carbamoylphosphate synthetase 
(CPS), (the rate-limiting enzyme in the urea cycle), is present in the periportal, intermediate and first 
few layers of the perivenous zone. CPS is absent in the very last downstream perivenous hepatocytes, 
in which glutamine synthetase (GS) is expressed.  We wished to determine the expression patterns 
of GS and CPS during development of the mouse embryonic liver, using a combination of 
immunostaining and western blotting techniques.     
The Wnt/-catenin pathway is an evolutionarily conserved signalling cascade that plays a key role in 
development and adult tissue homeostasis and is aberrantly activated in many tumours. For example, 
the APC gene was among the first tumour suppressors to be cloned. A germline APC mutation is the 
genetic cause of a hereditary cancer syndrome termed Familiar Adenomatous Polyposis (FAP) 
(Kinzler et al., 1991; Nishisho et al., 1991). FAP patients inherit one defective APC allele and as a 
consequence develop large numbers of colonic adenomas, or polyps, in early adulthood. Loss of both 
APC alleles occurs in the large majority of sporadic colorectal cancers (Kinzler and Vogelstein, 
1996). Loss-of-function mutations in Axin have also been found in hepatocellular carcinomas, 
whereas oncogenic -catenin mutations occur in a wide variety of solid tumours (Reya and Clevers, 
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2005). In liver, the Wnt/-catenin pathway has been found to play a key role in metabolic zonation 
of adult liver, regeneration and hepatocellular carcinogenesis (reviewed in Thompson and Monga, 
2007). Although -catenin is central to liver biology, its upstream effectors remain obscure. 
Classically, there are 19 Wnt and 10 Frizzled genes in the mouse genome. One previous study 
identified 11 Wnts and 9 Frizzleds that are normally expressed in the adult mouse liver (Zeng et al., 
2007). However the expression of individual Wnt or Frizzled genes during liver development is not 
known. As the first step towards understanding the role of the Wnt/-catenin pathway in liver 
development, we determined the expression profile of members of the Wnt pathway (listed in Table 
3-1) using in situ hybridization from mouse embryonic day 11.5 (E11.5) to E18.5.  
 
Table 3-1 Target mRNAs for in situ hybridization 
  












3.2.1 Expression of CPS and GS during development 
In order to investigate the role of the Wnt/-catenin signalling pathway in the development of 
zonation, we also analysed the expression of two key genes that are heterogeneously distributed 
across the liver lobule and are involved in ammonia detoxification: the periportal marker, 
Carbamoylphosphate synthetase (CPS) and the perivenous marker, Glutamine synthetase (GS). We 
used mouse livers dissected from E12.5 to E18.5. Western blotting and immunostaining techniques 
were applied to determine the spatio-temporal expression of the CPS and GS proteins. 
Total protein was extracted from mouse embryonic livers at E12.5, 13.5, 14.5, 15.5, 16.5, 17.5 and 
18.5 and probed for CPS and GS expression (Figure 3.1). In agreement with previous studies 
(Notenboom et al., 1997), CPS became expressed between E13.5 and E14.5 and gradually increased 
thereafter.  GS only became expressed between E17.5 and E18.5. 
To determine when the normal embryonic zonal expression pattern was established, we used 
immunostaining to determine the localisation of CPS and GS and in developing mouse embryos.  
We found that a few cells expressed CPS at E13.5 and E14.5 (Figure 3.2) but then the numbers 
increased and gradually the normal expression pattern became apparent with most hepatocytes 
expressing CPS in periportal, intermediate and the first few layers of the perivenous zone by E17.5. 





Figure 3.1 Expression of GS and CPS during embryonic development 
Cell extracts were prepared from embryonic livers from E12.5 to E18.5. 10g of protein from each 
sample was separated by electrophoresis on a 10% Tris-HCl gel and blotted onto PVDF membrane. 
Blots were probed with primary antibodies against GS, CPS or GAPDH and then with 





Figure 3.2 CPS protein starts to be expressed in liver around E13.5 days of mouse development  
OCT-embedded cryosections of embryonic livers were immunostained with anti-CPS and FITC 
conjugated secondary antibody. Only a few cells express CPS in the E13.5 liver (arrows) 






Figure 3.3 GS is expressed in liver of mouse embryos between E17.5 and E18.5 
Paraffin-embedded sections of embryonic livers were immunostained with anti-GS and horseradish 
peroxidise conjugated secondary antibody. The signal was detected by DAB staining. Haemotoxylin 
was used as a nuclear counterstain (Magnification X 200). Magnified image of E18.5 (arrowed) is at 






Figure 3.4 Regional distributions of GS and CPS in the liver of an E18.5 mouse embryo 
OCT-embedded cryosections of embryonic livers from E14.5 (a and e), E15.5 (b and f), E17.5 (c and 
g) and E18.5 (d and h) were immunostained with both anti-CPS (red) and anti-GS (green) antibodies. 




3.2.2 Expression of -catenin during development  
To determine the expression of activated -catenin versus total -catenin, we probed cytosolic and 
nuclear fractions using an antibody raised to the total (phosphorylated and dephosphorylated) of 
-catenin (Figure 3.5). Nuclear -catenin was transiently expressed at E12.5 and then gradually 
decreased. Although we found evidence of small amount of nuclear -catenin between E14.5 to 
E16.5, the highest levels were observed between E17.5 and E18.5 correlating with the peak of GS 
expression. 
Immunohistochemical analysis was performed to determine the localisation of -catenin during 
mouse liver development (Figure 3.6). Paraffin-embedded embryonic livers from E14.5 to E18.5 
were sectioned and probe to -catenin antibody. Nuclear -catenin was barely detectable at E14.5 
and E15.5. However, in agreement with the western blotting data (Figure 3.5), a robust nuclear 





Figure 3.5 Expression of -catenin in the developing mouse liver 
Nuclear and cytosolic extracts were prepared from embryonic livers from E12.5 to E18.5. 10ug of 
protein sample was separated by electrophoresis on 10% Tris-HCl gel and blotted onto PVDF 
membrane. Blots were probed with primary antibodies against -catenin, the nuclear protein 
LaminB1 or the cytosolic protein, GAPDH and then with HRP-conjugated secondary antibodies. The 
signal was detected by ECL chemiluminescence. Some weak nuclear -catenin expression was 







Figure 3.6 -catenin becomes activated between E17.5 and E18.5 
Paraffin-embedded sections of embryonic livers from E14.5, E15.5, E17.5 and E18.5 were 
immunostained with anti--catenin and HRP-conjugated secondary antibody. -catenin remains 
membrane bound form since E14.5. Nuclear -catenin became abundant between E17.5 and E18.5. 




3.2.3 Expression of Wnt pathway components during liver 
development 
3.2.3.1 Wnt4 
Wnt4 was not expressed during early liver development from E11.5 to E12.5 (Figure 3.7 I-J). Bi et al 
previously noted the expression by RT-PCR at E12.5 (Bi et al, 2009). In contrast, we found 
expression of Wnt4 from E14.5 in the embryonic liver and the signal remained strong until E18.5 
(Figure 3.7 K-N). We also observed expression in the mucosal lining of stomach and duodenum 
from E14.5 to E18.5, and lung, kidney and pancreatic primordium expression from E13.5 to E15.5. 
This was in accordance with previous studies conducted by RT-PCR on the digestive tract (Lickert et 
al., 2001) and whole-mount in situ hybridization during kidney ontogeny (Merkel et al., 2007), 
respectively. 
3.2.3.2 Wnt5a 
We did not detect Wnt5a expression in the mouse embryonic liver throughout E11.5 to E18.5. This 
was in agreement with the previous RT-PCR results (Bi et al, 2009). However, at stage E11.5, we 
found Wnt5a expressed in the medial and lateral nasal process, the primordium of the primary palate 
and the ventral extremity of lower jaw (Figure 3.8 H). The expression of Wnt5a was maintained in 
these tissues until stage E13.5 (Figure 3.8 I-J). This is the first time the localization of Wnt5a 
transcripts was closely observed during mouse development. The observation was consistent with the 
previous study of chicken craniofacial development which showed Wnt5a expression in maxillary, 
mandibular prominence, lateral nasal prominences and lateral edges of the frontonasal mass by 
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whole-mount in situ hybridization (Geetha-Loganathan et al., 2009). We also observed Wnt5a 
expression in the tips of branchial arch and lower limbs from E11.5 to E13.5. 
3.2.3.3 Wnt5b 
Wnt5b expression has not been shown in the mouse embryonic liver to date. In this study we clearly 
observed Wnt5b expression in the hepatic bud from E11.5 to E18.5 (Figure 3.9 H-N). We also found 
Wnt5b expression in the branchial arch, the mucosa of duodenum and stomach, heart and lung bud at 
E11.5 and E12.5; lung, mucosal lining of stomach, duodenum and metanephros at E13.5; lung, 
duodenum, pancreatic primordium and metanephros at E14.5 and E15.5; intestine, gastric mucosa 
and pancreas at E17.5 and E18.5. However previous RT-PCR results showed the absence of Wnt5b 
mRNA expression in mouse embryonic liver (Bi et al, 2009). This difference could be due to higher 
sensitivity of the in situ hybridization. This gastro-intestinal pattern of Wnt5b gene expression 
confirmed previous studies with RT-PCR on mouse embryonic digestive tract (Lickert et al., 2001) 
(Heller et al., 2002). 
3.2.3.4 Wnt9b 
We first observed Wnt9b expression at stage E11.5 in the hepatic buds and other tissues including the 
branchial arch, lung bud, mucosa of duodenum and stomach. The signal remained in these tissues 
until E12.5 (Figure 3.10 H-I). By stage E13.5, the Wnt9b expression gradually reduced and became 
undetectable in the liver and other tissues (Figure 3.10 J). This was in contrast with previous 
RT-PCR experiment showing expression through whole embryonic stages from E12.5 till E18.5 (Bi 
et al, 2009). 
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3.2.3.5 Frizzled 1 
We detected Fzd1 mRNA expression in the hepatic buds from E11.5 until E18.5 (Figure 3.11 H-N). 
This was in accordance with the previous results demonstrated by RT-PCR in mouse embryonic liver 
(Bi et al, 2009). We observed Fzd1 expression in other tissues including mucosa of duodenum and 
stomach, lung bud, main bronchus and heart at E11.5; lung bud, stomach and duodenum at E12.5; 
lung, mucosal lining of stomach, duodenum and metanephros (the definitive kidney) at E13.5 and 
E14.5; intestine, gastric mucosa and pancreas at E17.5 and E18.5. The expressions of the receptor in 
these tissues has not been reported previously but suggested a role for the Wnt/-catenin pathway in 
the development of these tissues. To date, this is the first comprehensive expression pattern for Fzd1 
to be conducted. 
3.2.3.6 Frizzled 2 
We did not observe Fzd2 signal at any of the early stages of mouse development (i.e. from E11.5 to 
E13.5). Fzd2 first appeared at stage E14.5 in the lung, kidney, duodenum and pancreatic primordium. 
Fzd2 expression persisted in these tissues up to stage E15.5 (Figure 3.12 K and L). At E17.5 and 
E18.5, we were still able to observe Fzd2 expression in the intestine tissue. However, Fzd2 signal 
was clearly excluded from the liver through E11.5 to E18.5. The gastro-intestinal expression was 
consistent with previous RT-PCR observations suggesting Fzd2 is broadly expressed in mouse 





We first observed Lrp5 expression at stage E11.5 in the hepatic buds and the signal remained until 
stage E13.5 (Figure 3.13 H-J). However, the Lrp5 expression was gradually lost from the liver after 
E14.5 (Figure 3.13 K-N). We also found Lrp5 in many tissues other than liver including the mucosa 
of the stomach and duodenum, the ventricular and atrial chambers of the heart, the midgut loop, 
branchial arch and lung bud at E11.5; lung bud, stomach and duodenum at E12.5; lung, mucosal 
lining of stomach, duodenum and metanephros at E13.5; lung, metanephros, adrenal gland and 
duodenum at E14.5; lung, kidney, adrenal gland, duodenum and pancreatic primordium at E15.5. Bi 
et al showed Lrp5 mRNA equally expressed throughout all embryonic stages from E12.5 to E18.5 
(Bi et al, 2009). However, in situ hybridization is more sensitive than PCR and our results 
demonstrate that Lrp5 expression decreased after E14.5. 
3.2.3.8 -catenin 
-catenin expression was first observed in the hepatic bud at E11.5 (Figure 3.14 H). By stage E14.5, 
-catenin was strongly expressed in the liver. However, the signal was gradually lost from the liver 
by stage E17.5. Previous data demonstrated peak expression of -catenin during early liver 
development at E10-E12, followed by a decrease and a complete loss of normal -catenin after E16 
through the remaining prenatal period (Micsenyi et al, 2004). We also observed -catenin expression 
in the cystic primordium (gall bladder), mucosa of stomach and duodenum, midgut loop, branchial 
arch, lung bud, main bronchus at E11.5; lung bud, stomach and duodenum at E12.5; lung, mucosal 
lining of stomach, duodenum and metanephros at E13.5; lung, cortical region of metanephros, 
pancreatic primordium and duodenum at E14.5; lung, cortical region of kidney, adrenal gland, 
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Figure 3.7 Wnt4 expression started from E14.5 during mouse liver development  
Sections were hybridized with sense (A-G) and anti-sense probes (H-N). Wnt4 was expressed in 
embryonic liver from E14.5 and remained strongly expressed until E18.5. Annotations as follows: h, 
heart; liv, liver; lu, lung; duo, duodenum; me, metanephros. O-U are higher magnification of livers 

















Figure 3.8 Wnt5a is expressed in frontonasal region during mouse development  
Sections were hybridized with sense (A-G) and anti-sense probes (H-N). We did not detect any 
Wnt5a expression in mouse embryonic liver. However, the maxillary expression of Wnt5a was 
observed from E11.5 to E13.5 in a variety of tissues. Annotations as follows: h, heart; liv, liver; lu, 
lung; duo, duodenum; me, metanephros; j, lower jaw; br, branchial arch; lo, lower limb; na, nasal 
process. O-U are higher magnification of livers from H-N. Scale bars in A and H represent 350 m; 







Figure 3.9 Wnt5b is expressed throughout E11.5 to E18.5 in developing mouse liver 
Sections were hybridized with sense (A-G) and anti-sense probes (H-N). Wnt5b was expressed in 
mouse embryonic liver from E11.5 to E18.5. Annotations as follows: h, heart; liv, liver; lu, lung; 
duo, duodenum; me, metanephros. O-U are higher magnification of livers from H-N. Scale bars in A 







Figure 3.10 Expression of Wnt9b was restricted in E11.5 and E12.5 during mouse liver 
development 
Sections were hybridized with sense probes (A-G) and anti-sense probes (H-N) to Wnt9b . Magnified 
areas were shown in the framed upper right corner corresponding to the pointed region. Wnt9b 
expression in the embryon was restricted to between E11.5 and E12.5. Annotations as follows: h, 
heart; liv, liver; lu, lung; duo, duodenum; me, metanephros. O-U are higher magnification of livers 








Figure 3.11 Fzd1 is expressed from E11.5 to E18.5 during mouse liver development  
Sections were hybridized with sense (A-G) and anti-sense probes (H-N) to Fzd1. Magnified areas 
were shown in the framed upper right corner corresponding to the arrow pointed region. Fzd1 was 
expressed in the mouse embryonic livers throughout the stages of development examined from E11.5 
to E18.5. Annotations are as follows: h, heart; liv, liver; lu, lung; duo, duodenum; me, metanephros. 
O-U are higher magnification of livers from H-N. Scale bars in A and H represent 350 m; in O 







Figure 3.12 Fzd2 is not expressed in developing mouse liver from E11.5 to E18.5  
Sections were hybridized with sense (A-G) and anti-sense probes (H-N) to Fzd2. Fzd2 expression 
was not expressed in the mouse embryonic liver at any of the stages examined (E11.5 to E18.5). 
Annotations are as follows: h, heart; liv, liver; lu, lung; duo, duodenum; me, metanephros. O-U are 








Figure 3.13 Lrp5 is expressed in mouse liver during E11.5 to E13.5  
Sections were hybridized with sense (A-G) and anti-sense probes (H-N) to Lrp5.  Lrp5 was 
expressed in the embryonic liver only at early stages of development from E11.5 to E13.5. 
Annotations are as follows: h, heart; liv, liver; lu, lung; duo, duodenum; me, metanephros. O-U are 








Figure 3.14 Robust -catenin expression during E11.5 to E13.5 in mouse liver  
Sections were hybridized with sense (A-G) and anti-sense probes (H-N) to -catenin. -catenin was 
found to be strongly expressed from E11.5 but then the expression was gradually reduced after 
E17.5. Annotations as follows: h, heart; liv, liver; lu, lung; duo, duodenum; me, metanephros. O-U 
are higher magnification of livers from H-N. Scale bars in A and H represent 350 m; in O 




The overall aim of the research described in the present chapter was to determine the expression 
pattern in developing mouse liver for two enzymes involved in ammonia detoxification (CPS and GS) 
as well as members of the Wnt/-catenin signalling pathway.  We found that CPS protein became 
expressed between E13.5 and E14.5 and gradually increased thereafter while GS protein only 
became expressed between E17.5 and E18.5. This finding is in agreement with previous study 
conducted by Notenboom et al (1997). 
The expression of urea cycle enzymes in hepatocytes, including CPS, varies between mammalian 
species. In rat and mouse hepatocytes, CPS expression is not observed until the beginning of the fetal 
period (Dingemanse et al., 1996; Gaasbeek Janzen et al., 1988; Moorman et al., 1990; Morris et al., 
1989). However, in hepatocytes of human embryos, the expression of this enzyme begins shortly 
after the liver has differentiated from the embryonic foregut (Dingemanse and Lamers, 1994; van 
Roon et al., 1990). These interspecies differences in the developmental appearance of ornithine cycle 
enzymes in the liver are probably related to the intrauterine growth rate of the embryo (Dingemanse 
and Lamers, 1994; Meijer et al., 1990)  
Previous in situ hybridization studies (Kuo and Darnell, 1991; Moorman et al., 1990) have revealed a 
strong and homogenous expression of GS mRNA in the liver of early mouse and rat (E13) embryos. 
However Janzen et al, 1987 could only demonstrate GS protein expression until E20 in rat 
hepatocytes, whereas Bennett et al, 1987 reported that mouse hepatocytes already contained 
immunohistochemically detectable amounts of GS at E15. The accumulation of GS protein in fetal 
hepatocytes following the onset of transcription appears to be delayed in both species. The reason for 
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this delay can be either a poor translational efficiency or instability of the protein in the early 
embryonic liver (Notenboom et al., 1997). 
The discrepancy in the developmental appearance of GS protein in rat and mouse liver was also 
described by Notenboom et al, 1997. The authors suggested that GS starts to accumulate in mouse 
liver at E15 and Shiojiri et al, 1995 reported that GS immunoreactivity is not observed in mouse liver 
until 2-3 days after birth. These discrepancies could depend upon the effective antigen concentration 
of GS, antiserum generated from different laboratories and the fixation protocol. It has been reported 
that addition of glacial acetic acid to the fixation medium dramatically dimished 
immunohistochemiscal staining of GS in perinatal hepatocytes. Here we applied GS monoclonal 
antibody instead of pooled antiserum which was widely use in previous studies described above in 
immunohistochemistry analysis and western blotting to demonstrate more accurate GS expression. 
We show that GS protein expression only became apparently between E17.5 and E18.5 around 
central vein. 
Micsenyi et al, (2004) showed peak expression of -catenin during early liver development at 
E10-E12, followed by a decrease of -catenin after E16 through the remaining prenatal period from 
microarray, northern and western blotting analysis. Here, in situ hybridization results shows 
abundant expression of -catenin mRNA at E11.5 and E12.5 and western blotting showed more 
nuclear -catenin protein expression at E12.5 that declined after E14.5. This data are in agreement 
with previous report (Micsenyi et al, 2004). However immunohistochemistry and fractionation 
followed by western blotting analysis revealed more detailed localization of -catenin in which 
nuclear -catenin, instead of membrane/cytosol -catenin, was barely detectable at E14.5 and E15.5 
116 
 
and became robust between E17.5 and E18.5. This activated -catenin is suggested to correlate with 
the induction of GS expression during perinatal stages described earlier in the discussion. 
Although the Wnt/-catenin pathway has been shown to be crucial in liver biology, the expression of 
Wnt and Frizzled genes during mouse development remains undetermined. Zeng et al, (2007) 
reported a total of 11 Wnts and 6 Frizzleds were expressed in normal adult mouse liver. Bi et al, 
(2009) determined the endogenous expression of the 19 Wnt genes identified so far in mice. Using 
semi-quantitative RT-PCR analysis, they demonstrated that the expression of 13 of the 19 Wnt genes 
was detectable. These include Wnt1, 2, 2B, 3, 3A, 4, 5A, 6, 8A, 9B, 10A, 10B, and 16. Among them, 
Wnt2B, 3A, 4, 8A, 9B, 10A, and 10B were highly expressed at all of the tested stages of liver 
development. Wnt2 and 5A were expressed at the later stages (e.g., 1 week after birth), while Wnt6 
and 16 were expressed at the early stages (e.g., before E14.5) of liver development. These results 
suggest that Wnt family members may exert a diverse effect on hepatic differentiation. On the other 
hand, all ten Fzd receptors and both LRP5 and 6were expressed in the isolated liver tissues. These 
results indicate that the expression of Wnt receptors and co-receptors is rather ubiquitous and 
abundant during liver development.  
Bi et al examined the expression patterns of the components of Wnt signalling pathway in embryonic 
livers from freshly prepared mouse liver tissues. Embryonic liver buds were pooled together, minced 
and homogenized in TRIZol Reagents. It is highly possible to collect mixed cell populations through 
this protocol and the data described is limited by RT-PCR results which as well as the technique 
demonstrating relatively poor sensitivity. Here we demonstrated the expression of the Wnt signalling 
genes by in situ hybridization to reveal a more comprehensive and temporal expression pattern 
during mouse liver development. 
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The differences between our result and previous reports were summarized in Table 3-2. The 
expression of the members in Wnt/-catenin pathway was also demonstrated in other organs such as 
lung, heart, intestine and kidney which will provide valuable information for further study.  
Table 3-2 Summary of results of in situ hybridization 
 
  E11.5  E12.5  E13.5  E14.5  E15.5  E17.5  E18.5  
Fzd1 
This thesis +  +  +  +  +  +  +  
Bi et al,2009 +  +  +  +  +  +  +  
Fzd2 
This thesis -  -  -  -  -  -  -  
Bi et al,2009 +  +  +  +  +  +  +  
Lrp5 
This thesis +  +  +  +  -  -  -  
Bi et al,2009 + +  +  +  +  +  +  
Wnt4 
 
This thesis -  -  -  +  +  +  +  
Bi et al,2009   + + + + + + 
Wnt5a 
 
This thesis -  -  -  -  -  -  -  
Bi et al,2009 -  -  -  -  -  -  -  
Wnt5b 
 
This thesis +  +  +  +  +  +  +  
Bi et al,2009 NA NA NA NA NA NA NA 
Wnt9b 
 
This thesis +  +  -  -  -  -  -  
Bi et al,2009 + + + + + + + 
-catenin 
 
This thesis +  +  +  +  +  -  -  
Micsenyi et al, 2004 +  +  +  +  +  -  -  
NA: not available 
We were unable to detect liver expression of Fzd2 in contrast to Bi et al (2009). The reason for the 
lack of liver expression could be due to inadequate penetration of the probe into the tissue, but since 
we detected Fzd2 expression in the intestine this appears unlikely. RT-PCR is the most convenient 
method for the detection of low-abundance mRNA. However, it is a complex technique and there are 
substantial problems associated with its true sensitivity, reproducibility and specificity as a 
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quantitative method (Bustin, 2000).The data above suggests the Wnt pathway may exert different 
effects at different stages of liver development. In next chapter, we aimed to dissect the molecular 
basis of Wnt signalling in early liver development using conditional deletion of the Wnt effectors, 




CHAPTER 4 CONDITIONAL DELETION 
OF APC DURING EMBRYONIC 
DEVELOPMENT PERTURBS THE 





Wnt signalling pathways has been implicated in playing important role in hepatogenesis. Ober et al 
described the requirement in zebrafish for mesodermally-derived Wnt signals, acting through the 
canonical pathway, for specification of the hepatic endoderm (Ober et al, 2006). The temporal 
regulation of -catenin in the developing mouse liver is implicated in biliary cell differentiation and 
in promoting liver growth and hepatocyte maturation (Monga et al, 2003). The most direct linkage 
between the Wnt/-catenin pathway and zonation regulation, however, is the demonstration that liver 
tumours in mice carrying activating mutations in either -catenin or Ha-ras exhibit altered zonal 
gene expression. That is, tumours carrying -catenin mutations express GS throughout the lesion, 
whereas Ha-ras tumours are negative for GS but express E-cadherin (a periportal marker) 
(Hailfinger et al, 2006). It is observations such as this, from liver tumours, that first suggested that 
-catenin may be required for mediating the expression of zone-specific genes. Recently, using 
conditional deletion technique Benhamouche et al and our lab have established a role for the 
Wnt/-catenin pathway in regulating the zonation of ammonia detoxification along the portovenous 
axis in adult mice (Benhamouche et al 2006 and Burke et al, 2009). Therefore the aim of the research 
described in this chapter is to dissect the role of Wnt/-catenin pathway during liver development 
especially hepatic zonation. 
Previous studies on the knockout of -catenin or Apc in hepatoblasts resulted in mid to late 
gestational lethality between E16.5 to E18.5 (Tan et al., 2008; Decaens et al., 2008). My data on the 
appearance of the zonal markers CPS and GS suggests that the periportal marker (CPS) is induced 
between E12.5-E13.5 days of mouse development (Figs 3.1-3.3) and the perivenous marker (GS) is 
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induced at a later stage (between E17.5 and E18.5, Figure 3.1). The fact that lethality occurred 
between E16.5 and E18.5 means that it is difficult to determine the direct effect of aberrant activation 
or loss of the Wnt/-catenin pathway on development of metabolic zonation (and in particular 
appearance of glutamine synthetase-expressing perivenous cells). To address this problem, we used a 
conditional approach for deletion of Apc by AhCre-mediated recombination. In the AhCre transgenic 
line, Cre expression is under the control of the Cyp1A1 promoter element that is normally 
transcriptionally silent but can be up-regulated in response to lipophilic xenobiotics such as 
-napthoflavone (NF) (Matsushita et al, 1993). The AhCre model provides an efficient approach 
for controlling Cre-mediated gene excision in the mouse liver and intestine (Ireland et al, 2004). 
AhCre mice were intercrossed with mice carrying the loxP flanked Apc allele:Apc580S (Apc
fl/fl
) and 
have been used in studies of intestinal pathology (Sansom et al., 2004) and adult hepatic zonation 
(Burke et al, 2009). Pregnant mice were identified and injected intraperitoneally with 3 doses of 
-NF over a 1-day period. The embryos were then removed from the pregnant females at the time 
points indicated and the embryonic livers isolated as described in the 2.2.7. The -NF injection time 
points and incubation periods were designed as Table 4-1. The tissues were processed for changes in 




Table 4-1 Study design of -NF injection induced Apc deletion in embryonic mouse liver 
 E12.5 E13.5 E14.5 E15.5 E16.5 E17.5 E18.5 
CPS 
expression 
  + + + + + 
GS 
expression 
      + 






   







Group 3   
-NF 
injection 
   
Isolate 
embryos 






Table 4-2 Markers of metabolic zonation 
Zonated metabolism 
Periportal Perivenous 
Ammonia, Amino acid 
Urea formation: Carbamoylphosphate 
synthetase (Cps); Arginase (Arg); 
Argininosuccinate synthetase (Ass); 
Argininosuccinate lyase (Asl); Glutaminase2 
Nitrogen metabolism: Glutamine synthetase 
(Gs), glutamate transporter 1 (Glt1)  








4.2.1 Effect of Apc deletion on zonation during development  
-NF was first injected to pregnant female mice at gestational day E13.5 and the embryos were 
isolated at E15.5. To confirm the loss of Apc, immunohistochemistry for -catenin was performed 
(Figure 4.1). Nuclear accumulation of -catenin was observed in AhCre+Apcfl/fl livers (Figure 4.1, 
upper panel). As well as activation of -catenin, the expression of known perivenous markers (GS, 
RHBG, RNase4 and Glt1) were either induced or upregulated compared to RNA extracted from 
control (AhCre
-
) mouse liver (Figure 4.2). These changes were accompanied by a down-regulation of 
gene expression profile typical of a periportal phenotype (PEPCK, CPSI, ASL, ASS, Glutaminase2 
and Arginase) (Figure 4.2). 
To complement the changes in gene expression following Apc deletion, we also determined the 
expression of CPS and GS by immunohistochemistry (Figure 4.1) in pregnant female mice that were 
treated with -NF at E13.5 and the livers were removed at E15.5. Under normal circumstances GS 
protein is not expressed until between E17.5 and E18.5. However, GS was detected in cells 




 embryos (Figure 4.1, middle panel). The change in GS 
expression was accompanied by a reduction in CPS expression (Figure 4.1, lower panel). In order to 
test the temporal dependence of Apc deletion, we injected -NF into pregnant female mice at 
different stages of gestation. We injected -NF at gestational day E14.5 and E16.5 and the embryos 
were removed at E16.5 and E18.5 respectively (Table 4-1). Consistent with the results for injection 
at E13.5, in all examined groups, perivenous genes were up regulated and periportal gene expression 
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was reduced (Figure 4.1 and 4.2). Apc deletion showed a dramatic effect on liver zonation regulation 
during development.  
4.2.2 Apc deletion enhances cell proliferation  
-catenin activation is associated with an increase in cell proliferation and -catenin activation is 
frequently observed during tumour formation (Reya and Clevers, 2005). A decrease in cyclinD1 (a 
member of the cyclin protein family that is involved in regulating cell cycle G1/S progression) was 
seen in the -catenin-deficient livers, and this deficit became more pronounced during states 
requiring de novo cyclin D1 synthesis such as during liver regeneration after partial hepatectomy 
(Kato et al., 2005). These observations suggest a clear role of -catenin in normal liver growth. 
Impaired proliferation has also been observed in the -catenin knockout embryos by a decrease in 
number of Proliferating cell nuclear antigen (PCNA)-positive cells, especially after E14 (Tan et el, 
2008). Therefore we also determined the proliferative activity of cells using phospho-histone 3 (PH3) 





 livers compared to control (P<0.05) and an up-regulation of CyclinD1 RNA 




 livers injected with -NF at E14.5 and taken at E18.5 (Figure 
4.3). The up-regulation of PH3 in other groups with different injection time point and incubation 
period was not statistically significant (results not shown).  




Previously, it was suggested that -catenin may have a critical role in the biliary differentiation from 
hepatoblasts. In the absence of -catenin, there is a reduction in CK-19-positive primitive 
intrahepatic bile ducts (Hussain et al., 2004).  In order to test whether biliary differentiation was 
altered following deletion of Apc we investigated whether the activation of -catenin was 
accompanied by any changes in expression of ductalmarkers. We initially performed  
haematoxylin-eosin staining of sections taken from embryos that were treated with -NF at 
different stages of development (E13.5, E14.5, E14.5 and E16.5 and removed the tissues for 
processing at E15.5, E16.5, E18.5 and E18.5 respectively). In one group of embryos (treated at E16.5 




 mice (Figure 
4.4). To further elucidate the phenotype, we examined ductal morphogenesis by investigating the 
expression of the progenitor ductal marker, Sox9 (Figure 4.5). Sox9 is detected in the developing bile 














livers Sox9 was 
found scattered throughout the sections where the staining pattern in control sections formed a ring 
around the ductal-like structures. We also investigated the expression of other ductal markers 
including connexin43, cytokeratin7 and cytokeratin19.  We detected, by RT-PCR, an increase of 
expression of these ductal genes. Thus -catenin may therefore play an important role in regulating 
biliary differentiation during the E16.5 – E18.5 stage of development.  
In order to address the mechanisms underlying the ductal phenotype seen following Apc loss, we 
turned our attention to the Notch signalling pathway. The role of the Notch pathway in hepatoblast 
differentiation was demonstrated by immunohistochemical analysis of mid gestational embryos 
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(Tanimizu et al., 2004). Jagged1 was shown to be expressed in the cells adjacent to ductal plates 
surrounding the portal veins suggesting that the Notch signalling is activated in hepatoblasts that 
undergo differentiation into cholangiocytes. Activating Notch signalling pathway by expression of 
the Notch intracellular domain in hepatoblasts inhibited hepatic differentiation and significantly 
reduced the expression of albumin, a marker of both hepatoblasts and hepatocytes. By contrast, 
downregulation of the Notch signalling by siRNA specific for Notch2 mRNA as well as by the 
gamma-secretase inhibitor promoted hepatic differentiation (Tanimizu et al., 2004). 
The canonical Wnt pathway has been shown to regulate the Notch pathway genes (at least in the 
HT29 colorectal cancer cell line and in murine intestinal adenomas) (Ungerback et al., 2011). We 
hypothesized that the ductal phenotype may arise from the Wnt/-catenin pathway regulating ductal 
morphogenesis through the Notch signalling pathway. To investigate this possibility, we determined 
the expression of Notch downstream target genes including Hairy and enhancer of split 1 (Hes1), 
Hairy/enhancer-of-split related with YRPW motif protein 1 (Hey1) and Manic Fringe 
(Artavanis-Tsakonas et al., 1999). Only at the stage E16.5 to E18.5 (under the conditions where the 
ductal markers cytokeratin7, cytokeratin19 and connexin43 were upregulated), did we observe an 
up-regulation of Hes1, Hey1 and Manic Fringe (Figure 4.6).       
 
4.2.4 Characterization of the liver phenotype in 
catenin-deleted embryos 
In order to determine the embryonic liver phenotype in AhCre
+-cateninfl/fl embryos we injected 
NF at E14.5 and collected the embryos at E18.5. We found a decreased level of -catenin 
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expression (at both the RNA and protein levels) (Figure 4.7). We also determined the effect of 
deleting catenin on the expression of periportal and perivenous markers by both PCR and also by 
immunhistochemistry.  The perivenous markers (GS, Rhbg and Rnase4) were either absent or 
reduced in comparison with control livers.  In contrast, there was no obvious difference observed 
between control and AhCre
+-cateninfl/fl embryos for the periportal markers (Cps, Asl, Ass, 
Glutaminase2 and Arg) (Figure 4.7).  These data suggest that either deletion of -catenin is not 
sufficient to induce a change in the periportal phenotype or, that as well as -catenin, some other 




Figure 4.1 Changes in the expression of CPS and GS in in embryonic liver following 
conditional deletion of Apc. -NF was injected into pregnant female mice and embryos were 
isolated at different stages of gestation indicated on the top of the figure. Immunostaining for 
-catenin, CPS and GS in control (AhCre-) and AhCre+Apcfl/fl liver. Apc deletion induced nuclear 
accumulation of -catenin and complementary changes in GS and CPS protein expression during 




Figure 4.2 Deletion of Apc at different stages of development results in a change in the 
expression of periportal and perivenous hepatic markers.   
-NF was injected into pregnant female mice and embryos were isolated at different stages of 







(Apc-/-) mice for the periportal markers PEPCK, CPS, ASL, ASS, glutaminase2, 
Arginase and perivenous markers GS, RHBG, RNase4 and Glt1. Apc deletion induced 





Figure 4.3 Proliferative markers are increased in Apc-deficient liver. 
-NF was injected into pregnant female mice at E14.5 and embryos were isolated at E18.5. (A) 







(Magnification X 400) (B) Quantitative analysis of the numbers of phosphohistone H3-positive (PH3) 




 mice. PH3-positive cells were counted in the 10 
fields under 400X magnification. Significant differences are shown by * (T-Test, p<0.05). Bar 
















-NF was injected into pregnant female mice and embryos were isolated at different stages of 
gestation indicated on the top of the figure. Isolated embryonic livers were fixed, processed and 






 liver sections were stained with 






Figure 4.5 Deletion of Apc induces changes in hepatic ductal morphogenesis.  
-NF was injected into pregnant female mice and embryos were isolated at the stages indicated on 






 mice were 




Figure 4.6 Activation of Notch pathway downstream target genes in Apc deleted embryonic 
livers 
-NF was injected into pregnant female mice and embryos were isolated at the stages indicated on 













Figure 4.7 Deletion of -catenin results in a down-regulation in perivenous gene expression.   
-NF was injected into pregnant female mice at E14.5 and embryos were isolated at E18.5 of 
gestation. RT-PCR analysis for perivenous and periportal markers and immunostaining for -catenin, 
GS and CPS were performed on control (AhCre
-
) and AhCre
+-cateninfl/fl liver. -catenin deletion 
resulted in faint stained of -catenin and decrease in perivenous transcripts and GS protein 





The overall aim of the research described in this chapter was to dissect the role of the Wnt/-catenin 
pathway in the development of the embryonic liver and in particular the development of metabolic 
zonation or hepatocyte heterogeneity.  Previous studies had suggested a role for Wnt signalling in 
liver development.   However, the issue with these studies was that the loss of -catenin was lethal 
before the embryonic liver started to express the enzyme GS. Based on our data we saw that CPS 
expression was induced between E13.5 and E14.5 whereas GS became expressed between E17.5 and 
E18.5 (Figures 3.3 and 3.4).  We therefore sought to capitalize on a conditional deletion model we 
previously used to investigate the role of the Wnt/-catenin pathway in the induction of hepatic 
zonation in the adult mouse liver (Burke et al, 2009).  We used AhCre mice to conditionally delete 
Apc or -catenin at different stages of liver development.  The AhCre  mice were generated by 
using the promoter of the rat Cyp1A1 gene to drive Cre recombinase expression.  The Cyp1A1 gene 
is not transcriptionally active but can be induced by lipophilic xenobiotics acting through the aryl 
hydrocarbon receptor (Ah) (Nebert et al., 2000). The mechanism of Cyp1A1 gene expression 
involves the binding of the xenobiotic to the cytoplasmic Ah receptor which is normally bound to 
Hsp-90.  Once the xenobiotic binds, the Ah receptor dissociates from the Hsp-90.  The 
dissociation then permits the Ah receptor to translocate to the nucleus where it probably interacts 
with other factors (including Ah receptor nuclear translocator (ARNT)) to activate the promoters of 
responsive genes including the Cyp1A1 gene. In the adult, recombination occurs in the liver and 
intestine following administration of -NF (Ireland et al., 2004). We and others had previously 
shown that the Cre was active in the adult mouse liver (Burke et al, 2009; Ireland et al 2004).  We 
confirmed that the Ah-Cre transgene was responsive in the embryonic liver since following treatment 
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of the pregnant female mice with -NF at the times indicated, -catenin accumulates in the liver 
(Figure 4.2).  The data suggest that the -NF can be used for inducing transplacental Cyp1A1 
activity in the embryos and that these mice could be used for studying conditional deletion of genes 
in the developing mouse liver. 
While we know something about the role of the Wnt/-catenin pathway in the maintenance of 
zonation in the adult liver, there is a lack of information on whether the pathway is also critical for 
the induction of zonation in the developing mouse liver. To address this shortfall we initially deleted 
Apc at different stages of liver development. We found for the first time that the Wnt/-catenin 
pathway may also be responsible for inducing zonation (at least for the ammonia detoxification 
pathway). The most remarkable result came from the group while we deleted Apc in embryonic mice 
at E14.5, incubated for 4 days and analysed at E18.5. With disruption of the Apc gene, nuclear 
-catenin was observed in the majority of cells, indicating activation of Wnt signalling in liver. Gene 
expression analysis revealed an alteration in a number of genes, including an increase in GS, the 
glutamate transporter Glt1, and the ammonia transporter RhBG. GS and Glt 1 have previously been 
reported as -catenin target genes (Cadoret et al., 2002); hence, changes in expression after deletion 
of Apc are consistent with previous observations. We also examined the periportal genes and found a 
complementary loss of genes, suggesting a switch in phenotype from periportal to perivenous-like 
hepatocytes.  
We observed a significant increase in the number of PH3-positive cells and an up-regulation of 









livers injected with -NF at E14.5. This correlation between Wnt/-catenin and embryonic liver 
proliferation was also seen in -catenin deleted in the developing hepatoblasts utilizing Foxa3-Cre 
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and floxed--catenin transgenic mice from E8 to E8.5 (Tan et al, 2008). Deletion of -catenin in 
developing livers resulted in significantly underdeveloped livers after E12. Histological analysis of 
the mice revealed a decreased cyclin-D1 and impaired proliferation (Tan et al, 2008). 
From haematoxylin-eosin staining of sections taken from in the -NF induced AhCre+Apcfl/fl 
embryos (Figure 4.4), we saw an accumulation of ductal-like structures. Staining for progenitor 





. This was accompanied with an up-regulation of expression of other ductal markers 
transcripts including connexin43, cytokeratin7 and cytokeratin19 suggested Wnt/-catenin may play 
an important role in regulating biliary differentiation during the E16.5 – E18.5 stage of development. 
This is consistent with previous studies showed that -catenin may play important role in biliary 
specification during liver development. Monga et al, showed that -catenin antisense ablation in E10 
liver cultures led to an absence of cytokeratin-positive biliary cells (Monga et al, 2003). Growth in 
Wnt3a-conditioned media showed survival and proliferation of predominantly Cytokeratin 
19-positive cells as compared with the control media (Hussain et al., 2004). Tan et al, suggested 
-catenin deletion in embryonic livers resulted in a markedly decreased of cytokeratin19 positive 
cells in the primitive ductal plates E16 or E18 stages (Tan et al, 2008). Decaens et al further 
described a partial commitment of Apc deleted hepatoblasts to biliary lineage while the activation of 
-catenin signalling in hepatoblasts induced premature, mislocalized, and incomplete differentiation 
of these cells toward the biliary lineage. We have tried to further analyse the ductal phenotype 
induced by Apc deletion using immunostaining for ductal markers such as Cytokeratin7, 
Cytokeratin19, Connexin43 and Sox9. However we could only successfully detected Sox9 
expression in either paraffin sections or cryosections. This could be due to the problems of staining 
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conditions or might indicate these are premature ductal-like structures as suggested by Decaens et al. 
The detail mechanism of -catenin activation induced premature biliary differentiation reeds further 
investigation.  
We have also characterized liver phenotypes of AhCre
+-cateninfl/fl embryos. -catenin deletion 
resulted in reduced of the perivenous markers, however there was no obvious difference observed for 
the periportal markers. In previous study for zonation maintenance in adult mice, deletion of 
-catenin induced a loss of GS and a complementary increase of CPS (Burke et al, 2009). The 
discrepancy from results of adults and embryos suggested that the regulation of periportal genes 
expression might be different during development. Deletion of -catenin is either not sufficient to 
induce a change in the periportal phenotype or, that as well as -catenin, some other mechanisms 
might be involved in regulating hepatic zonation in the periportal region during embryonic 





CHAPTER 5 DIRECTED 
DIFFERENTIATION OF EMBRYONIC 
LIVER TOWARDS A PERIPORTAL OR 
PERIVENOUS-LIKE PHENOTYPE BY 






Culturing embryonic tissue in an in vitro setting offers the unique ability to manipulate the external 
medium and therefore to investigate the pathways involved in regulating normal organogenesis as 
well as providing models for developmental disorders. In vitro organ culture also provides a useful 
tool for studying the mechanisms involved in regulating normal organogenesis. Embryonic tissues 
including pancreas (Burke et al, 2010), liver (Burke et al, 2010), lung (Carraro et al., 2010), kidney 
(Zhang et al., 2012) and salivary glands (Spooner et al., 1989) have all been successfully cultured 
with the developing organs exhibiting many of the morphological features specific to their tissue 
type. One advantage provided by using an in vitro model is that the affect of exogenous factors on 
development can be monitored directly, thereby eliminating the need for lengthy procedures in which 
transgenic animal models have to be generated and maintained.  
Herein we use in vitro culture of embryonic mouse liver to investigate the role of the Wnt/-catenin 
pathway in the developing liver. The liver tissue was dissected from E11.5 mouse embryos (see 
section 2.2.8). The buds were then placed on fibronectin-coated coverslips in Basal Medium 
Essential (BME) medium supplemented with 10% FBS, penicillin (100U/ml), streptomycin 
(100g/ml) and 2mM L-glutamine and allowed to attach. Over the next few days, the buds grow as 





5.2.1 Characterisation of the in vitro liver culture model  
5.2.1.1 Characterization of the in vitro culture model 
The protocol here we used is based on a modification of the technique described by Percival and 
Slack (Percival and Slack, 1999).  We have applied this technique to studying pancreas 
development and transdifferentiation in an in vitro setting (Kurash et al., 2004; Shen et al., 2003; 
Shen et al., 2000; Thowfeequ et al., 2007).  More recently we have established a protocol for the 
maintenance of embryonic liver in culture (Burke et al, 2010).  The culture system allows the 
embryonic liver tissue to grow as a flattened structure. This approach facilitates analysis of the tissue 
by enabling efficient wholemount immunostaining without the requirement for sectioning small and 
delicate samples.  
Within hours of culture, the liver buds adhered to the fibronectin-coated coverslips. Gradually over 
the next few days, the explants flatten out and mesenchymal cells migrate out from the original buds 
to form a monolayer surrounding and covering the epithelium (Figure 5.1). 
To address the role of the Wnt/-catenin pathway in regulating metabolic zonation in developing 
liver, we initially monitored the expression of the perivenous marker, Glutamine synthetase (GS) in 
the in vitro liver bud culture model (Figure 5.2). Liver buds dissected from E11.5 mouse embryos 
were cultured in serum-containing BME medium in the presence of 1M Dex. By day 7, 
differentiated hepatocyte-like cells started to express the GS protein. The expression peaked on day 9 
and then declined at day 11 (Figure 5.2). 
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5.2.1.2 Optimization of adenoviral infection in cultured liver buds 
While one key advantage of the embryonic liver culture model is the easy manipulating we also felt 
that the ability to ectopically express genes of interest may also be an important goal.  Previous 
attempts by members of the lab showed that the cultured liver tissue was refractory to ectopic gene 
expression by transfection (Kuang-Ming Liu and David Tosh, personal communication).  We 
therefore considered alternative approaches to gene transfection to achieve ectopic gene expression.  
One possibility was test the utility of adenoviral infection. We therefore chose a replication-defective, 
first generation adenoviral approach for gene delivery as actively dividing cells are not required for 
infection and the virus exhibits a broad range of infectivity in mammalian tissues and up to 8kb of 
genetic material can be transferred.  Moreover the adenovirus does not integrate into the host 
genome and remains epichromasomally.   
We first tried to optimize the conditions for adenoviral infection. To address this we used an 
Ad-RSV-GFP vector to infect cultured liver buds.  The Ad-RSV-GFP uses the Rous sarcoma virus 
(RSV) promoter to drive GFP expression.  Liver buds were dissected from E11.5 mouse embryos 
and cultured in serum containing BME medium in the presence of 1M Dex. Once the buds attached 
to the fibronectin-coated coverslips after approximately 24hrs, Ad-RSV-eGFP was added to the 
medium at an M.O.I. of 100. This M.O.I was chosen based on our previous experience with using 
adenovirus infection of embryonic tissues (Quinlan et al., 2006).  The media containing the virus 
was removed after 24 hours of incubation and replaced with fresh medium. Live images were 
collected after two days of infection (72hrs of culture).  Robust GFP protein was expressed in the 
buds (Figure 5.3) suggesting good infection was achieved. I have also tried to infect cultured buds 
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with M.O.I. of 10 and 200. The result of infection with M.O.I. of 10 showed poor infection rate and 
M.O.I. of 200 lead to the buds detaching.    
We wished to know whether GFP was expressed in the epithelium and/or mesenchymal component 
of the liver buds.  To demonstrate protein expression in the cultured buds, liver explants were 
isolated and allowed to attach on fibronectin-coated coverslips for 24hrs.  The virus was then 
applied for 24hr and then the medium was removed and the explants were then cultured for a further 
48hr after which they were fixed and subjected to immunostaining for anti-GFP and anti-E-cadherin 
(an epithelial marker) antibodies. GFP was shown in both E-cadherin positive and 
E-cadherin-negative epithelial cells (Figure 5.4). This result indicates that the adenoviral vectors can 
successfully infect and carry the targeted genes to the epithelium layer of the liver cells in the 
cultured buds.     
5.2.1.3 Effect of modulators of the Wnt/-catenin pathway on expression of periportal and 
perivenous markers in cultured embryonic liver  
In section 5.1.1, we showed that GS began to be expressed in the liver buds around Day 7 in the 
presence of 1M Dex. To provide sufficient time to see an affect we decided to infect adenoviral 
genes (which could alter the activity of Wnt/-catenin pathway) on Day 5 of culture and collect the 
samples on Day 10 for analyses.  
E11.5 buds were isolated and cultured in the presence of 1M Dex for 5 days. To activate the 
Wnt/-catenin pathway, we infected the liver buds with adenoviral vectors carrying the Wnt ligands, 
Wnt1 and Wnt5a. Virus were incubated for 24hrs and replaced with fresh medium containing 1M 
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Dex. Medium with freshly added Dex was then replaced every other day, After 5 days of incubation, 
the buds were collected and then subjected to immunostaining and RNA extraction. Compared to 
control, (which was infected with Ad-null to control for the adenoviral infection), the number of cells 
expressing GS was dramatically increased in the Ad-Wnt1 infected groups (Figure 5.5 and 5.8). In 
contrast, following infection with Ad-Wnt5a the number of GS-expressing cells was only modestly 
increased compared with infection of Ad-Wnt1 (Figure 5.5 and 5.8).  Similarly, GS was also 
slightly up-regulated following ectopic expression of -catenin, in the cultured liver buds (Figure 5.6 
and 5.8). 
We tested the use of a novel and selective small molecule inhibitor of glycogen synthase kinase 3 
(GSK-3) termed TD114-2 (Bone et al, 2009). TD114-2 can robustly inhibit GSK-3 in mouse 
embryonic stem cells (ESCs) and enhance ESC self-renewal (Bone et al, 2009). In contrast, addition 
of TD114-2 to human ESCs has quite distinct effects and promotes differentiation towards the 
hepatoblast stage of liver differentiation (Bone et al., 2011).  In vitro assays suggested that TD114-2 
has an IC50 value for GSK-3- inhibition of 3nM, and in mouse ESCs TD114-2 treatment leads to 
activation of the canonical Wnt pathway, exemplified by decreased -catenin phosphorylation and 
activation of TCF/LEF transcriptional activity (Bone et al, 2009). E11.5 buds were isolated and 
cultured in the presence of 1M Dex for 5 days. TD114-2 was then added to the culture medium to 
the final concentration of 1M. Medium with freshly added Dex and TD114-2 was then replaced 
every other day, After 5 days of incubation, the buds were collected and then subjected to 
immunostaining and RNA extraction. After treated with TD114-2, GS expression was increased in 
the culture livers based on both immunostaining and RT-PCR results (Figure 5.6 and 5.8).  
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Other than activating the Wnt/-catenin pathway, we also tried to block the Wnt pathway by 
infecting the buds with an adenoviral vector carrying the Dickkopf (DKK1) gene. DKK1 is a 
secreted protein with two cysteine rich regions and is involved in embryonic development through its 
inhibition of the Wnt pathway (Semenov et al., 2001). DKK1 blocks the Wnt pathway as a high 
affinity antagonistic ligand to LRP6, which is a Wnt co-receptor (Mao et al., 2001). By the same 
procedures described above, with the Ad-DKK1 infection for 5 days (Figure 5.7), GS expression was 
decreased in the cultured liver buds. 
To complement the immunostaining data we carried out RT-PCR analysis of the liver buds following 
infection with Ad-Wnt1 and Ad-Wnt5a and Ad-DKK1 (Figure 5.8). We also performed RT-PCR 
analysis on RNA isolated from liver cultures treated with and without the GSK3 inhibitor TD114-2.  
We found that in agreement with the immunostainng data, Wnt1, Wnt5a and TD114-2 all increased 
expression of GS whereas DKK inhibited GS expression.  
Surprisingly, infection with Ad--catenin did not enhance GS gene expression based on the RT-PCR 
analysis (Figure 5.8). We suspected it is much easier for adenovirus to infect mesenchymal than 
epithelial cells in the in vitro culture setting. Wnt1, Wnt5a and DKK are all secreted proteins which 
might still exert their effect on epithelial cells via both paracrine (when they infect mesenchyme) and 
autocrine mechanisms (when they infect the epithelial cells). -catenin is a downstream effector in 
the Wnt/-catenin pathway therefore can only alter the pathway in the infected cells. The lack of 
changing in GS expression following Ad--catenin infectionmay reflects this limitation. The other 
point is that the transgene expression was only confirmed by hemagglutinin (HA) immunostaining 
for Ad-HA-tagged Wnt1 and RT-PCR for DKK1 transcripts expression (data not shown). Further 
techniques need to be established to confirm Ad--catenin and Ad-Wnt-5a expression.         
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From the results above, we clearly showed that manipulating Wnt/-catenin pathway leads to a 
marked effect on the expression of the perivenous marker, GS, in an in vitro model of liver 
development.   
5.2.1.4 Challenges of monitoring CPS expression with Dex treated liver buds culture model 
To address the role of Wnt-catenin pathway in regulating metabolic zonation in developing liver, 
we needed to provide evidence that not only the perivenous expression profile (e.g. GS) but also 
periportal gene expression (e.g. CPS) was also affected. We therefore dissected liver buds from 
E11.5 mouse embryos and cultured them in serum-containing BME with addition of Dex to final 
concentration of 1M. We have shown that CPS starts to be expressed in embryonic liver between 
E13.5 and E14.5 (Figure 3.1).  Based on our previous experience we predicted that in the in vitro 
culture system, CPS should become detectable from about Day3 or even later due to lack of the 
natural liver microenvironment.  Surprisingly, CPS showed robust expression at both the RNA and 
protein levels in the liver buds after only 24 hours of Dex treatment suggesting that the 
glucocorticoid is able to induce the premature expression of CPS (Figures 5.9 and 5.10). From the 
literature we realized that the glucocorticoid receptor binds directly to the distal promoter of CPS 
(Schoneveld et al., 2005).  The premature expression of CPS in the Dex-treated cultures makes it 
more difficult to use this culture system as a model for looking at how members of the Wnt/-catenin 
pathway regulate CPS expression. Therefore we moved on to test other supplements other than Dex 
which could also induce embryonic liver bud maturation.       
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5.2.2 Enhanced maturation of embryonic liver in culture 
following treatment with ITS  
To find an alternative to Dex we searched the primary literature. Previous reports of 
Insulin-Transferrin-Selenium (ITS) suggested it could be a potential candidate. ITS was first 
designed to be used as a supplementation to FBS thereby allowing for a reduction in the FBS culture 
requirements. Later, studies showed that ITS, Dex and the addition of growth factors (such as HGF 
and EGF) are important factors in the maintenance of the liver phenotype in hepatocyte cultures 
(Oyadomari et al., 2000; Sato et al., 1999).  ITS has been shown to be effective in enhancing the 
proliferation and survival of primary hepatocytes while Dex has been reported to promote the 
expression of a hepatocyte phenotype through the suppression of cell division (Chivu et al., 2009; 
Michalopoulos et al., 2003). 
Insulin is a hormone that promotes glucose and amino acid uptake by the cell. It is thought that 
mitogenic effects of insulin are due to the insulin-like growth factor receptor, IGF-1 receptor 
(Brameld et al., 1995). Transferrin is an iron transport protein that functions to transport iron to the 
cell. The protein also serves to detoxify the medium from oxygen radicals and peroxidase. Selenium 
is a cofactor that activates glutathione peroxidase, a player in the detoxification of oxygen radicals 
(Meredith, 1988). 
To determine the effect of ITS on the hepatic phenotype, we dissected E11.5 liver buds and cultured 
the explants in BME with addition of 1x ITS (ITS Liquid Media Supplement 100x, Sigma, UK). Gs 
and Cps RNA expression were determined by RT-PCR (Figure 5.11). Gs expression peaked around 
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day 7 of culture while Cps started to be expressed by day 3 after ITS treatment on the liver buds 
dissected from E11.5 mouse embryos. The result suggested culture with ITS could lead to liver buds 
maturation in a more reasonable timeframe in terms of Gs and Cps expression according to in vivo 
data (Figure 3.1). Therefore we decided to infect ITS cocultured liver buds with Ad-Wnt1 and 
Ad-DKK1 and monitor both CPS and GS expression. 
5.2.2.1 Effect of ectopic Wnt1 and DKK1 on expression of CPS and GS in cultured embryonic mouse 
liver  
We cultured embryonic for 5 days in BME and supplemented with ITS.  Thereafter we infected 
liver buds with Ad-null, Ad-Wnt1 or Ad-DKK1 viruses on Day5 of culture (at an M.O.I. of 100) and 
collected samples for analysis on Day10. Immunostaining results showed that the perivenous marker, 
GS, was induced in the buds infected with Ad-Wnt1 and suppressed in the buds infected with 
Ad-DKK1. Conversely, the expression of the periportal marker CPS was suppressed in the buds 
infected with Ad-Wnt1 and increased in the buds infected with Ad-DKK1 (Figure 5.12). This effect 
has also been confirmed at the RNA level (Figure 5.12).    
5.2.2.2 Effect of TD114-2 and Quercetin on developing liver  
While the application of the Wnt1 and DKK1 adenoviruses to the cultured embryonic livers 
demonstrated a role for the Wnt/-catenin pathway in establishing the zonation of ammonia 
metabolizing enzymes, we also decided to strengthen this data using pharmacological application of 




TD114-2, is a chemically synthesized novel small-molecule which can activate the Wnt/-catenin 
pathway through inhibition of GSK-3 (Bone et al., 2009). Quercetin is a plant-derived flavonoid 
widely distributed in the nature. Studies showed that Quercetin is also a potent inhibitor against 
Wnt/-catenin pathway (Park et al, 2005). Nuclear -catenin conveys signals though interaction with 
the Tcf/Lef family of transcription factors. In the absence of a Wnt signal, TCF/LEF factors bind 
DNA at Wnt-responsive genes and interact with other factors (e.g. Groucho, histone deacetylase) to 
repress transcription. -catenin binding to TCF/LEF proteins provides a transcription activation 
domain so target gene expression is activated. The binding of Tcf complexes to its specific binding 
sites are strongly suppressed by Quercetin treatment of colon cancer cells (Park et al., 2005). 
We initially tested the concentration dependence of TD114-2 and Quercetin on the morphology of 
the embryonic mouse livers maintained in BME with ITS for up to 7 days. TD114-2 was added to 
the culture medium up to final concentrations of 0, 0.2, 1and 2M (Figure 5.13).  Liver buds spread 
out and grew normally in the control and 0.2 and 1 M concentrations of TD114-2. However, the 
buds treated with 2M TD114-2 appeared to lose their epithelial cells. Therefore based on these 
observations we chose to treat the liver buds with 1M TD114-2 for subsequent experiments. 
Quercetin was added to the culture medium to final concentrations of 0, 10, 50 and 100 M (Figure 
5.14). Liver buds spread out and grew normally in the control even in media supplemented with the 
highest concentration of 100M Quercetin. Therefore we chose to treat buds with 100M Quercetin 
in later experiments. 
5.2.2.3 Treatment of embryonic liver cultures with TD114 and Quercetin alters the expression of 
ammonia detoxifying enzymes  
150 
 
E11.5 liver buds were dissected and cultured in serum containing medium with addition of TD114-2 
or Quercetin on Day5 to the concentration of 1M and 100 M, respectively. RNA was extracted 
from samples on Day10 of culture and subjected to RT-PCR analysis. Results indicated that 
perivenous genes (e.g. Gs and Glt1) were down-regulated and periportal genes (e.g. Cps and Pepck) 
were up-regulated in Quercetin-treated buds (Wnt pathway suppression) (Figure 5.15). In 
TD114-2-treated buds (Wnt pathway activation), perivenous genes were up-regulated and periportal 
genes were down-regulated (Figure 5.15). The result fit with our hypothesis that the Wnt/-catenin 





Figure 5.1 Morphological changes in mouse embryonic liver buds cultured in the presence of 
Dexamethasone. 
Liver buds were dissected from E11.5 mouse embryos and maintained in complete BME 
supplemented with 1M Dex for 1, 2, 3 and 7 days (Magnification X 200). Magnified image of Day7 







Figure 5.2 Time course of GS expression in embryonic liver buds maintained in culture  
Liver buds were dissected from E11.5 day old embryos as described in the Materials and Methods 
sections.  The buds were then cultured with 1M Dex for up to 11 days.  The embryonic tissue 
was fixed and immunostained for GS (red) and counterstained with the nuclear stain DAPI (blue). 






Figure 5.3 Cultured liver buds are amenable to adenoviral infection 
Liver buds were cultured with 1M Dex for 24 hours and then infected with Ad-eGFP (M.O.I. 100) 
for 24 hours. Live imaging of the embryonic buds shows that GFP was expressed in the buds after a 




Figure 5.4 Adenovirus infects both E-cadherin-positive and negative embryonic liver cells  
Liver buds were cultured with 1M Dex for 24 hours and then infected with Ad-eGFP (M.O.I. 100) 
for 24 hours. After 48 hours, the buds were immunostained for the epithelial marker, E-cadherin (red) 
and counterstained with DAPI. GFP was expressed (B). E-cadherin marked the epithelial region of 
the buds (C). A merged image of GFP and E-cadherin is shown in (D) and demonstrates that GFP 
was expressed both in the E-cadherin positive (epithelial) and E-cadherin (presumptive mesenchymal 





Figure 5.5 Adenoviral infection of Wnt1 and Wnt5a induces GS expression in cultured liver 
buds 
Liver buds were cultured with 1M Dex for 5 days and then infected with Ad-null (M.O.I. 100) 
(A-C) as control, Ad-Wnt1 (M.O.I. 100) (D-F) or Ad-Wnt5a (M.O.I. 100) (G-I) for 24 hours at 37℃. 
The virus was then removed and the buds were supplied with fresh medium. After 5 days, buds were 
fixed and immunostained for the perivenous marker, GS (red) and counterstained with DAPI. Both 
Ad-Wnt1 and Ad-Wnt5a appeared to enhance the number (and intensity) of cells expressing GS 
protein. C, F and I (Magnification X 200) are the higher magnification from B, E and H 





Figure 5.6 Adenoviral infection of -catenin or treatment with TD114-2induces GS expression 
in cultured embryonic liver buds 
Liver buds were cultured with 1M Dex for 5 days and infected with Ad-null (M.O.I. 100) (A-C) as 
control or Ad--catenin (M.O.I. 100) (D-F) for 24 hours at 37℃. The virus was then removed and 
the medium was replaced with fresh medium. After 5 days, the buds were fixed and subject to 
immunostaining. TD114-2 (1M) (G-I) was added in the medium on day 6 with Dex and cultured 
until 10 days prior to fixation. Fixed buds were then immunostained for the perivenous marker, GS 
(shown in red) and counterstained with DAPI. Both Ad--catenin and TD114-2 treatment induced 
expression of GS protein. C, F and I (Magnification X 200) are the higher magnification images from 






Figure 5.7 Ectopic DKK1 expression suppressed GS in cultured embryonic liver buds 
Liver buds were cultured with 1M Dex for 5 days and then infected with Ad-null (M.O.I. 100) 
(A-C) as control or Ad-DKK1 (M.O.I. 100) (D-F) for 24 hours at 37℃. After 5 days of culture, buds 
were fixed and immunostained for GS (red) and also counterstained with DAPI. Ad-DKK1 
suppressed expression of GS protein.B and E (Magnification X 200) are higher magnification images 






Figure 5.8 GS gene expression is associated with Wnt/-catenin pathway manipulation 
Liver buds were cultured for 5 days in the presence of 1of Dex were then infected with 
adenovirus or treated with TD114-2. Total RNA was extracted from liver buds infected with 
Ad-Wnt1, Ad-Wnt5a, Ad--catenin, and Ad-DKK1 or treated with TD114-2 on day 10.  2g of 
RNA was reverse transcribed. 100ng of the cDNA was amplified by PCR using specific primers to 
the GS gene (Upper panel). Ad-Wnt1, Ad-Wnt5a and TD114-2 induced GS expression; Ad-DKK1 
repressed GS gene expression; Ad--catenin in contrast did not really alter GS expression. The 
relative mRNA expression of selected genes was shown in each culture conditions. Data are fold 
































Figure 5.9 CPS expression is induced in embryonic liver cultures following Dex treatment 
Liver buds were cultured in the absence (-) and presence of 1M Dex for 1 and 2 days and then fixed.  
We then immunostained fixed tissue for CPS (shown in red) and counterstained with DAPI (shown 
in blue). The results demonstrate that CPS starts to be expressed on Day 1 following Dex treatment. 





Figure 5.10 Dex treatment induces Cps expression in liver bud explants 
RT-PCR analysis of RNA extracted from liver buds cultured with absence and presence 1M Dex 






Figure 5.11 Time course of Gs and Cps gene expression in ITS-treated liver cultures  
RNA was extracted from liver buds cultured with 1xITS for 3, 5, 7, 11 and 13 days. The results show 
that Gs starts to be expressed on Day 5 while the Cps gene begins to be expressed between Day3 and 





Figure 5.12 Adenoviral expression of Wnt1 and DKK1 induces complementary changes in Cps 
and Gs in ITS-treated liver buds 
Liver buds were cultured with ITS for 5 days and then infected with Ad-null (M.O.I. 100) (A-C) as 
control, Ad-Wnt1 (M.O.I. 100) (D-F) or Ad-DKK1 (M.O.I. 100) (G-I) for 24 hours at 37℃. The 
virus was then removed and fresh medium added to the liver buds. After 5 days, the buds were 
subjected to RT-PCR analysis (B) or alternatively fixed and immunostained for Gs (green), Cps (red) 
and counterstained with DAPI (A). Ad-Wnt1 induces Gs expression and suppresses Cps expression 
while Ad-DKK1 induces the converse changes in the phenotype. (A-I: magnification X 200; 





Figure 5.13 Morphological changes in mouse embryonic liver buds culture with TD114-2. 
Liver buds were dissected from E11.5 mouse embryos, cultured on fibronectin-coated coverlips and 





Figure 5.14 Morphological changes in liver buds following culture with Quercetin. 
Liver buds were dissected from E11.5 mouse embryos, cultured on firbonectin and incubated without 















Figure 5.15 Quercetin and TD114-2 induce complementary changes in periportal and 
perivenous genes in cultured embryonic liver buds 
Liver buds were cultured in the presence of ITS and Quercetin (100M) or TD114-2 (1M) was 
added for 10 days. Following RNA isolation, RT-PCR analysis was performed. (A) The results 
showed that TD114-2 induces perivenous gene expression (Gs and Glt1) and suppresses periportal 
gene expression (Cps and Pepck) while Quercetin induces complementary changes in the phenotype. 
(B) The relative mRNA expression of selected genes in each culture conditions was shown as bar 










































































































The aim of the research described in this chapter was to translate the results obtained from the in vivo 
transgenic mice to an in vitro setting. We specifically wished to examine the direct effect of 
modulating the Wnt-catenin pathway on the development of the zonation of ammonia detoxifying 
enzymes CPS and GS. To address this aim we used an in vitro model of embryonic mouse liver 
development previously developed in the lab (Burke et al, 2010). Liver tissue was dissected from 
E11.5 mouse embryos and chopped into small sized buds. The buds were placed into cloning rings 
on fibronectin-coated coverslips in BME medium supplemented with 10% FBS, penicillin (100U/ml), 
streptomycin (100g/ml) and 2mM L-glutamine and allowed to attach. Over the next few days, the 
buds grow as flattened structures and can be subjected of wholemount immunostaining methods, 
protein and RNA analysis. 
Buds dissected from E11.5 embryos and cultured for 7 days may be equivalent to E18.5 in vivo 
although in vitro culture might result in a slight delay in maturation compared to in vivo due to lack 
of soluble factors secreted from endothelial cells such as Vascular endothelial growth factor, (VEGF), 
hepatic mitogen, hepatic growth factor (HGF), and interleukin-6 (IL-6) which have been reported to 
support hepatocyte survival and proliferate (Coultas et al., 2005). In Chapter 3, we demonstrated that 
GS first became detectable between E17.5 and E18.5 in vivo (Figure 3.1). Our in vitro data (Figure 
5.2 and Figure 5.11) showed only 1-2 days delay compared to in vivo data therefore shows some 
correlation with the in vivo data suggesting that the liver buds were maintained under conditions that 
promoted hepatic growth and differentiation.  
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This in vitro culture system also provided us with a feasible tool to manipulate the culture 
environment. By changing the component in the medium, we can easily activate or block the 
signalling pathway during the buds growth and monitor its effect for example morphology and 
viability. Previous attempts by members of the lab showed that the cultured liver tissue was 
refractory to ectopic gene expression by transfection (Kuang-Ming Liu and David Tosh, personal 
communication). Herein, we took advantage of previous established standard protocol in the lab to 
generate and amplify adenovirus carrying interested gene fragments and showed high infection 
efficiency to the culturing liver buds. 24 hrs incubation of culturing liver buds with adenovirus 
carrying GFP genes showed robust GFP protein expression in buds including epithelial component. 
The liver buds culture described here also provided a potential platform for drug screen especially 




CHAPTER 6 MOLECULAR BASIS OF THE 
CONVERSION OF PANCREATIC 






Transdifferentiation is the conversion of one differentiated cell type to another and may occur either 
with or without cell division (Beresford, 1990; Tosh and Slack, 2002). A number of in vitro models 
have been developed by our lab for converting pancreatic cells to hepatocytes, including the rat 
pancreatic amphicrine call line AR42J-B13 (B13) (Shen et al. 2000) and cultured mouse embryonic 
pancreas (Percival and Slack 1999).  The B13 cell line is a subclone derived from the parent AR42J 
cell line (Mashima et al, 1996).  The B13 line is more amenable to differentiation to the pancreatic 
-cell phenotype (Mashima et al, 1996).  Shen et al. (2000) have shown after culturing B13 cells 
with synthetic glucocorticoid dexamethasone (Dex) for 2 weeks that the cells can transdifferentiate 
into hepatocytes (Transdifferentiated hepatocytes or TD hepatocytes) and start expressing hepatocyte 
markers such as glucose-6-phosphatase, transferrin (TFN) and albumin. The induction of C/EBP-β 
has also been identified as part of the molecular basis of the switch. Transfection of C/EBPβ into 
B13 cells mimics Dex-induced transdifferentiation.  In contrast, introduction of the 
dominant-negative form of C/EBPβ (termed liver-inhibitory protein or LIP) prevents Dex-induced 
transdifferentiation of pancreatic B13 cells to hepatocytes.  
The time course of the Dex induced transdifferentiation of B13 cells was studied by Shen et al 
(2000). Some cells became flattened by 5 days, and some of these cells began to express 
glucose-6-phophatase. Albumin started to appear from 9 days, but only in those cells already 
expressing glucose-6-phophatase. These results indicate that transdifferentiation is a progressive 
process.  It is presumed that initially the cells lose the pancreatic phenotype; then they start to 
express hepatic genes that typical of fetal liver (e.g. -fetoprotein and transferrin); and later they 
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express larger amounts of albumin and other gene products characteristic of adult liver (e.g. Cyp3A1, 
UGT) (Tosh et al, 2002). 
The CCAAT-enhancer binding proteins (C/EBP) are basic region/leucine zipper (bZIP) transcription 
factors expressed during differentiation of adipose tissue and liver (Manchado et al., 1994) 
(Birkenmeier et al., 1989; Descombes et al., 1990). C/EBP was found induced after just three days of 
treatment with Dex and cells with activated C/EBP also showed reduction of amylase and induction 
of expression of glucose-6-phosphatase (Shen et al, 2000).  
Although transfection of C/EBPcaused a similar hepatic transdifferentiation programme to 
treatment of Dex, it did not cause the same degree of morphological flattening suggesting that 
additional factors may be required to produce a more differentiated hepatic phenotype from 
pancreatic cells. 
HNF4 is a protein that is abundant in both adult and fetal liver as well as the intestine (reviewed by 
Shen et al. 2003). Several studies have shown the importance of HNF4 in regulation of liver 
differentiation and regeneration (Li et al. 2000; Nagy et al. 1994). A knockout study in the fetal 
livers of mice revealed that as a consequence of HNF4 removal, some genes essential for liver 
function are absent e.g. HNF1 and the pregnane X receptor (PXR) (Li et al, 2000). The retinoid X 
receptor  (RXR) is involved in regulation of hepatic metabolism. RXR regulates cholesterol, 
fatty acid, bile acid, steroid and xenobiotic metabolism (Wan et al., 2000). 
Transdifferentiated cells induced by treatment with Dex also showed nuclear expression of 
HNF4(Shen et al.2000). Expression of HNF4 is first observed when oval cells differentiate 
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morphologically and functionally into hepatocytes and form basophilic foci (Nagy et al, 1994). 
HNF4 may be responsible for the final commitment of a small portion of oval cells to differentiate 
into hepatocytes (Nagy et al., 1994). The oval cells are thought to be the progeny of a liver stem cell 
compartment and evidence now exits indicating that these cells can participate in liver regeneration 
by differentiating into different hepatic lineage (Evarts et al., 1987; Tatematsu et al., 1985). 
To test the role of the liver-enriched transcription factor HNF4 we co-expressed C/EBP and 
HNF4 in B13 cells by using adenoviral infection. Results showed that ectopic expressed HNF4 
and C/EBPcould induce the expression of hepatic genes and morphological changes of B13 cells 





6.2.1 C/EBP and HNF4
transdifferentiationof pancreatic cells to hepatocytes  
6.2.1.1 Optimizing the infection efficiency of adenoviral vectors in pancreatic B13 cells  
B13 cells grow rapidly while being cultured in normal serum containing DMEM medium. Previous 
experience in the lab suggested that seeding the B13 cells at a lower density to start with might help 
with adenoviral infection (Al-Adsani et al., 2010). We initially determined the utility of infecting 
pancreatic B13 cells (seeded at a density of 30%) and infected at an M.O.I. of 100 for both 
Ad-HNF4 and Ad-GFP-C/EBPFigure 6.1). Infected cells were subjected to immunoflourescence 
staining for HNF4 and C/EBP four days after infection. The results showed that close to 100% of 
cells expressed HNF4 and 50% positive of cells expressed C/EBP. Based on the morphology, cell 
viability did not appear to be affected (Figure 6.1).   
6.2.1.2 Ectopically expressed HNF4 and C/EBP induce morphological changes in pancreatic B13 
cells 
B13 cells infected with adenoviral vectors expressing C/EBP and HNF4 showed changes in 
morphology under the transmitted light microscope (Figure 6.1). Cells infected with Ad-C/EBP 
alone showed a morphology similar to B13 cells infected with an Ad-null virus.  The cells infected 
with Ad-C/EBP were round in shape and small in size. In contrast, B13 cells infected with 
Ad-HNF4 adenovirus showed a more dramatic morphology change in which the cells become 
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larger and flatter and were more hepatocyte-like. We also tested combining C/EBP and HNF4 
transgenic expression on cellular morphology.  Similar changes were observed in Ad-HNF4 and 
Ad-GFP-C/EBP infected cells as for cells infect with Ad-HNF4alone.  
6.2.1.3 Ectopically expressed HNF4 and C/EBP induce a programme of hepatic gene expression 
To further characterize the Ad-HNF4 and Ad-C/EBPinfected B13 cells, we determined the 
phenotype of the cells by investigating hepatocyte-specificgene expression including transferrin, 
albumin, -fetoprotein and Carbamoylphosphate synthetase (CPS). As well as Ad-C/EBPwe also 
tested whether the addition of another member of the C/EBP family of transcription factors (Ad- 
C/EBP enhanced hepatic gene expression. 
After 4 days of infection, cDNA was reverse transcribed from mRNA isolated from cells either 
uninfected,  or infected with HNF4, C/EBP, C/EBP alone or in combination (HNF4 + 
C/EBP, HNF4 + C/EBPC/EBP + C/EBP and HNF4 + C/EBP + C/EBP (Figure 6.3). 
We looked at the expression of a panel of hepatic markers including Albumin (Alb), -fetoprotein 
(Afp), Pepck, Cps and Glt1. Compared to control (uninfected or Ad-null virus infected cells), the 
combination of Ad-HNF4 and Ad-CEBP alone appeared to be sufficient to induce the hepatic 
genes including Alb, Afp, Pepck, Cps and Glt1.         
6.2.1.4 Ectopic expression of HNF4 and C/EBP induce hepatic protein expression 
In order to test whether ectopic expression of HNF4 and C/EBP can induce proteins typical of 
hepatocytes we infected B13 cells with the two adenoviral vectors and four days later fixed the cells 
prior to immunostaining. Expression of hepatic proteins (including Albumin, -fetoprotein, CPS and 
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Transferrin) was observed in the B13 cells infected with the combination of Ad-HNF4 and 
C/EBP(Figures 6.4-8).    
6.2.1.5 Analysis of time course effect of HNF4 and C/EBPon hepatic gene expression  
To monitor the hepatic gene expression following Ad-HNF4 and Ad-C/EBP infection of 
pancreatic B13 cells, we collected cell extracts from day 2, day 4 and day 7 post infection and 
generated RNA for RT-PCR analysis. The expression of Alb and Afp mRNA peaked on day 4 after 
infection and decreased dramatically thereafter (Figure 6.9).   
6.2.1.6 OSM does not enhance CEBP and HNF4 derived transdifferentiation 
A number of growth factors have been implicated in the early development of liver (Zaret, 2002). 
Oncostatin M (OSM), a member of the interleukin 6 cytokine family promotes differentiation of 
rodent hepatocytes in culture (Miyajima et al., 2000). Treatment of human fetal hepatocyte cultures 
with OSM increased cell size and enhanced cell differentiation and formation of bile canaliculi, 
probably through an effect on HNF4 (Lazaro et al., 2003).  We wished to know whether OSM 
could also improve CEBP and HNF4-induced transdifferentiation.  To address this point we 
added OSM to the culture medium 1 day after the pancreatic B13 cells were infected with CEBP 
and HNF4 Fresh medium containing OSM (10ng/ml) was replaced every other day during the 
4-day incubation. RT-PCR analysis showed that OSM treatment did not enhance the hepatic 
phenotype (Figure 6.10).     
6.2.1.7 The role of histone deacetylase inhibitors in transdifferentiation  
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Recently, new insights into the underlying molecular mechanisms have unveiled key regulatory roles 
of epigenetic marks driving cellular pluripotency, differentiation and proliferation (Atkinson and 
Armstrong, 2008; Yamashita et al., 2003). The transcription of genes, governing cell-fate decisions 
during development and maintenance of the differentiated status of a cell adult life, critically 
depends on the chromatin accessibility of transcription factors to genomic regulatory and coding 
chromatin modulation. 
A previous study demonstrated that trichostatin (TSA), a histone deacetylase inhibitor, is a potent 
inhibitor of cell proliferation and induces hepatocyte differentiation in human hepatoma cell lines 
(Yamashita et al., 2003). Valproic acid (VPA) and Sodium butyrate (NaB) are also histone 
deacetylase inhibitors and are under investigation for treatment of HIV and various cancers 
(Hrebackova et al., 2010; Routy et al., 2012). 
We examined the effect of addition of the histone deacetylase inhibitors TSA, VPA and NaB on 
CEBP and HNF4induced hepatic transdifferentiation of pancreatic B13 cells. B13 cells with 30% 
confluence were infected with Ad-null or Ad- CEBP and Ad- HNF4TSA. After 24hrs of infection, 
TSA, VPA and NaB were added to the medium to final concentration of 15nM, 0.5mM and 0.5mM, 
respectively. RNA were collected 4 days after adenovirus infection and subjected to RT-PCR 
analysis. Figure 6.11 showed that there was no dramatic difference between B13 cells infected with 
Ad-CEBPand Ad-HNF4and B13 cells infected with Ad-CEBPand Ad-HNF4treated with 
the histone deacetylase inhibitors TSA, VPA and NaB.    
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6.2.2 Role of the Wnt/-catenin signalling pathway on 
transdifferentiation of pancreatic cells to hepatocytes 
It has previously been reported that AR42J-B13 cells express Wnt signalling components [e.g. 
glycogen synthase kinase 3 (GSK3)], -catenin and several T-cell factor/lymphoid enhancer factor 
(Tcf/Lef) (Wallace et al., 2009). The expression of many of these genes is modulated by 
glucocorticoid in such a way as to suggest that the Wnt signalling activity is probably suppressed in 
AR42J-B13-derived hepatocyte-like cells (Wallace et al, 2009). Wright and colleagues in 2010 
reported that glucocorticoid-dependent transdifferentiation of B13 cells into hepatocytes is dependent 
on transient suppression of WNT signalling (Wallace et al., 2010). The authors showed that 
glucocorticoid treatment resulted in a transient loss of constitutive WNT3a expression, 
phosphorylation and depletion of -catenin, loss of -catenin nuclear localisation, and significant 
reduction in T-cell factor/lymphoid enhancer factor (Tcf/Lef) transcriptional activity before overt 
changes in the phenotype into hepatocyte-like cells. The authors refer to the hepatocyte-like cells as 
B-13/H cells.  A return to higher Tcf/Lef transcriptional activity correlated with the re-expression of 
WNT3a in B-13/H cells.  Quercetin - a Tcf/Lef inhibitor - did not promote transdifferentiation into 
B-13/H cells, but did potentiate glucocorticoid-mediated transdifferentiation. These data demonstrate 
that the transdifferentiation of B13 cells into hepatocyte-like cells in response to glucocorticoid was 
dependent on the repression of constitutively active WNT signalling. A serine/threonine kinase 
termed SGK1 has also been suggested to play a crucial role in B13 transdifferentiation to 
hepatocytes through direct phosphorylation of -catenin (Wallace et al., 2011).  
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To further examine the role of Wnt/-catenin pathway in transdifferentiation, Quercetin, TD114-2 or 
DKK1was added to our Dex induced B13 transdifferentiation model. 
6.2.2.1 Quercetin and TD114-2 
Quercetin is a Tcf/Lef inhibitor (Park et al, 2005). We attempted to repeat the experiment described 
by Wallace et al (2010), Quercetin was added to the culture medium to a final concentration of 
50M (Wallace et al 2010) (Figure 6.12). Cells were treated for 14 days and then subjected to 
RT-PCR analysis. Quercetin alone resulted in the induction of mRNA encoding CEBP/ but not 
Albumin or Cyp2e1.In contrast to the data provided by Wright et al (Wallace et al., 2010).  
To determine whether activating the Wnt/-catenin pathway through inhibition of GSK3 is important 
for transdifferentiation, we utilized our novel GSK3 inhibitor TD114-2.  We used the inhibitor at a 
concentration of 0.2M. Cells were cultured for 7 or 14 days and RT-PCR analysis of Albumin and 
-fetoprotein were performed (Figure 6.13). Figure 6.13 demonstrated that treatment with TD114-2 
resulted in a reduction of Albumin mRNA, producing a lower level of expression than Dex treatment, 
however Quercetin treatment did not result in the elevation of albumin and apha-fetoprotein mRNA 
expression. The over-exposure of the bands shown in the last three lanes of the albumin mRNA in 
Figure 6.13 indicate that the conditions of the experiment were not optimized and reduced amount of 
template or cycle numbers may be worth testing in the future. 
6.2.2.2 DKK1 
DKK1 is a secreted protein and blocks the Wnt pathway as a high affinity antagonistic ligand for 
LRP6, which is a Wnt co-receptor (Tamai et al., 2000). To examine whether DKK1 activity is crucial 
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for transdifferentiation, B13 cells were either treated with DKK1 recombinant protein or infected 
with Ad-DKK1 adenovirus. Figure 6.14 demonstrated that neither DKK1 protein nor DKK1 





Figure 6.1 Morphological changes in pancreatic cells B13 cells following infection with 
Ad-C/EBP and/or Ad-HNF4. 
B13 cells were infected with Ad-null (M.O.I. 200), Ad-C/EBP (M.O.I. 100), Ad-HNF4(M.O.I. 
100) or both for 24 hours at 37℃. The virus was then removed and the cells were supplied with fresh 
medium. Live images were taken 4 days after infection. Ad-HNF4induces a dramatic morphology 
changes in B13 cells. The cells become larger and flatter. In contrast, the B13 cells infected with 





Figure 6.2 Expression of C/EBP and HNF4in B13 cells following adenoviral infection 
B13 cells were infected with Ad-C/EBP (M.O.I. 100) and Ad-HNF4(M.O.I. 100) for24 hours at 
37℃. The virus was then removed and the cells were supplied with fresh medium. Infected cells 





Figure 6.3 Ectopic expression of C/EBP and HNF4induces hepatic transdifferentiation of 
pancreatic B13 cells 
Total RNA was isolated from B13 cells on Day 4 following adenoviral infection. RT-PCR analysis 
using specific primers for hepatic genes including Alb, Albumin; Afp, -fetoprotein; Pepck, 
phosphoenolpyruvatecarboxykinas; Cps, Carbamoylphosphate synthetas; Glt1, Glutamate 




Figure 6.4 C/EBP and HNF4induces AFP protein expression in B13 cells  
B13 cells were infected with Ad-C/EBP (M.O.I. 100) and Ad-HNF4(M.O.I. 100) for24 hours at 
37℃. The virus was then removed and cells were supplied with fresh medium. Infected cells were 
immunostained for AFP (red) and counterstained with DAPI. Result shows that Ad-C/EBP and 





Figure 6.5 Albumin protein was induce in B13 cells after ectopic C/EBP and HNF4  
B13 cells were infected with Ad-C/EBP (M.O.I. 100) and Ad-HNF4(M.O.I. 100) for24 hours at 
37 ℃. Virus was then removed and cells were supplied with fresh medium. Infected cells were 
immunostained for Albumin (red) and counterstained with DAPI. Result shows that Ad-C/EBP and 





Figure 6.6 C/EBP and HNF4induce E-cadherin protein expression in B13 cells  
B13 cells were infected with Ad-C/EBP (M.O.I. 100) and Ad-HNF4(M.O.I. 100) for24 hours at 
37 ℃. Virus was then removed and cells were supplied with fresh medium. Infected cells were 
immunostained for E-cadherin (red) and counterstained with DAPI. Result shows that Ad-C/EBP 






Figure 6.7 Ectopic C/EBP and HNF4induce Transferrin protein expression in B13 cells  
B13 cells were infected with Ad-C/EBP (M.O.I. 100) and Ad-HNF4(M.O.I. 100) for24 hours at 
37 ℃. Virus was then removed and cells were supplied with fresh medium. Infected cells were 
immunostained for Transferrin (red) and counterstained with DAPI. Result shows that Ad-C/EBP 






Figure 6.8 Ectopic C/EBP and HNF4induce CPS protein expression in B13 cells  
B13 cells were infected with Ad-C/EBP (M.O.I. 100) and Ad-HNF4(M.O.I. 100) for24 hours at 
37 ℃. Virus was then removed and cells were supplied with fresh medium. Infected cells were 
immunostained for CPS (red) and counterstained with DAPI. Result shows that Ad-C/EBP and 





Figure 6.9 Time course of expression of hepatocyte markers following adenoviral infection of 
C/EBP and HNF4  
Total RNA was purified from B13 cells on Day 2, 4 and 7 after infection with the Adenoviral vectors 
indicated in the figures. RT-PCR analysis was performed using specific primers for the hepatic genes 
shown including Alb, Albumin and Afp, -fetoprotein. Result suggested that C/EBP and 





Figure 6.10 OSM did not enhance C/EBP and HNF4induced hepatic transdifferentiation 
of pancreatic B13 cells 
Total RNA was isolated from B13 cells on day 4 after infection with the Adenoviral vectors 
indicated in the figures.  Oncostatin M (OSM 10ng/ml) was added to B13 cells 24hrs after infected 
with Ad-C/EBP and Ad-HNF4. RT-PCR analysis using specific primers for hepatic genes 
including Alb, Albumin; Afp, -fetoprotein; Cps, Carbamoylphosphate synthetase and Glt1, 




Figure 6.11 C/EBP and HNF4directed transdifferentiation of pancreatic B13 cells to 
hepatocytes was not altered by the addition of inhibitors of histone deacetylase 
Total RNA were purified from B13 cells on 4 after infected with Adenoviral vectors indicated in the 
figures with or without addition histone deacetylase inhibitors (NaB, VPA and TSA). RT-PCR 
analysis using specific primers for hepatic genes including Alb, Albumin; Afp -fetoprotein; Cps, 
Carbamoylphosphate synthetase and Glt1, Glutamate transporter 1. Results showed that there was 





Figure 6.12 Inhibition of Tcf/Lef activity alone does not stimulate transdifferentiation 
Dex and Quercetin were added to the medium 24hrs after cell seeded. Total RNA were purified from 
B13 cells on 14 after cultured in the medium with Quercetin (50M) or Dex (1M). RT-PCR 
analysis was performed using specific primers for hepatic genes including C/EBP, Cyp2e1 and 






Figure 6.13 Quercetin and TD114-2 do not stimulate transdifferentiation of pancreatic B13 
cells to hepatocyte-like cells 
Total RNA was purified from B13 cells on Day14 after cultured in the medium with Quercetin 
(50M), TD114-2 (0.2M) with or without Dex (1M). RT-PCR analysis was performed using 
specific primers for hepatic genes including Alb, Albumin and Afp, -fetoprotein. Results showed 





Figure 6.14 Ectopic expression of DKK1 does not stimulate hepatic transdifferentiation of 
pancreatic B13 cells 
Total RNA was purified from B13 cells on Day2, 5, 8 and 14 after cultured in the medium with 
Ad-DKK1 infection (M.O.I. 100) or addition of DKK1 soluble protein with or without Dex (1M). 
RT-PCR analysis was performed using specific primers for hepatic genes including Alb, Albumin and 








Previous studies from our laboratory have shown that the synthetic glucocorticoid Dexamethasone 
(Dex) is able to induce the transdifferentiation of pancreatic B13 cells to hepatocyte-like cells (Shen 
et al, 2000).  While the transfection of the liver-enriched transcription factor C/EBP into 
pancreatic B13 cells can induce a hepatic phenotype, the morphological changes associated with Dex 
treatment are lacking.  This suggests that additional factors were necessary to induce hepatic 
morphogenesis of the pancreatic B13 cells.  One candidate transcription factor that might be 
involved in this process is HNF4 
HNF-4a is a transcription factor of the nuclear hormone receptor family that is expressed in the 
hepatic diverticulum at the onset of liver development. Examination of the mouse complementation 
of HNF4a (-/-) embryos with a tetraploid embryo-derived wild-type visceral endoderm revealed that 
HNF4α is dispensable for specification of the hepatic lineage. However HNF4α is essential for the 
expression of genes that define a fully differentiated hepatocyte phenotype (Li et al., 2000). The ex 
vivo morphogenetic potential of HNF4 has been analysed using HNF4-null embryonic hepatic 
cells and livers (Hayhurst et al., 2008). Using mice floxed for HNF4, hepatic cells lacking 
HNF4were isolated placed into primary culture and subsequently derived into cell lines. 
HNF4-null cells show no difference with control cells in regeneration ability and expression of 
major cell lineages. However loss of HNF4 in vivo may induce stress response that interferes with 
liver morphogenesis.  
Our results demonstrated that ectopic expressed of HNF4couldinduce hepatic morphological 
changes of B13 cells to a more flattened phenotype. However either HNF4or C/EBPalone is not 
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sufficient to induce hepatic differentiation of B13. Only co-expressed of C/EBP and HNF4could 
induce morphological changes of B13 cells reminiscent of hepatocytes and induction of hepatic 
specific gene expression.  
The maximal infectious rate of Ad-GFP-C/EBPwas about 50%. To enhance the hepatic phenotype 
higher infection rates could be achieved by addition of diethylaminoethyl dextran (Sambrook et al, 
1989) or alternatively a lentivirus system may be applied for further evaluation. Other strategies such 
as culturing in the lower concentration of serum may be an option. However if lowering the serum 
would lead to low cell viability need further examination. Ectopic expression of other liver enriched 
transcription factors may also improve the hepatic phenotype. For example, Hnf4α plus Foxa1, 
Foxa2 or Foxa3 have been demonstrated that can convert mouse embryonic and adult fibroblasts into 
cells that closely resemble hepatocytes in vitro (Sekiya and Suzuki, 2011).The phenotype of 
C/EBPHNF4co-expressing cells could be examined in more detail for example the study of liver 
function, such as albumin secretion, bioconjugation of xenobiotics and ammonia removal.  
The flavonol-type flavonoid Quercetin has increased in popularity because it is a highly studied, 
multidimensional bioactive compound that possesses both antioxidant properties and the ability to 
modulate many signal transduction pathways including canonical Wnt, phosphatidylinositol 3 
(PI3)-kinase (Giuliani et al., 2008) and extracellular signal-regulated kinese (ERK) (Li et al., 2012) 
mediated signalling pathways. Previous studies had shown that Quercetin could rapidly induce 
UDP-glucuronosyltransferase (UGT) in the human intestinal cell line Caco-2. The induction of UGT 
by Quercetin pretreatment was studied both in the intact cells and cell homogenates, measured as the 
glucuronidation of Quercetin, and by immunoblot analysis of the UGT 1A protein (Galijatovic et al., 
2000). The complexity and rapid metabolism of Quercetin make it a challenge to repeat the previous 
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published results. Wright and colleagues showed that transient suppression of Wnt signalling is 
necessary for glucocorticoid-dependent transdifferentiation of B13 cells into hepatocytes is 
dependent (Wallace et al, 2010). I have tried to further investigate this phenomenon by adding two 
compounds, Quercetin and TD114-2, and one recombinant protein, DKK1 into our Dex induced B13 
transdifferentiation model. However I failed to reproduce the same result described previously. The 
reason could be due to the difference between cell clones or other unknown factors which might need 




CHAPTER 7 FINAL DISCUSSION AND 
FUTURE PROSPECTS  
Liver is the largest internal organ and it provides many essential metabolic, exocrine and endocrine 
functions. Embryonic liver development has been substantially studied for many years (Zaret and 
Grompe, 2008). Originating from the ventral foregut endoderm, embryonic liver receives induction 
cues from adjacent developing heart at E9.0. At E9.5, the hepatic endoderm cells, known as 
hepatoblasts delaminate from the epithelium and invade the adjacent septum transversum 
mesenchyme to form the liver bud. Between E10-15 the liver bud undergoes a period of accelerated 
growth as it is vascularized and colonized by hematopoietic cells to become the major fetal 
hematopoietic organ. Establishment of the lobular liver architecture during the perinatal period is 
accompanied by zonal gene regulation. Some liver enzymes are expressed in periportal regions while 
other enzymes are expressed in perivenous regions. The compartmentalization of function 
determined by the position of hepatocytes within the lobule makes it possible for liver to carry many 
different metabolic pathways effectively and efficiently. Although hepatic zonation is critical for its 
normal function, the molecular mechanism underlying the phenomenon were poorly understood until 
studies demonstrating the role of the Wnt/-catenin signalling pathway in the maintenance of 
zonation in the adult liver. Benhamouche et al and our lab have established a role for the Wnt 
pathway in maintenance the zonation of ammonia detoxification in adult mice (Benhamouche et al, 
2006; Burke et al, 2009). In this thesis, we uncover the role of Wnt/-catenin signalling pathway in 
regulating zonation in embryonic liver.  
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The motivation of this work was driven by mainly two scientific questions: 1.) when and where are 
members of the Wnt/-catenin pathway expressed during embryonic liver development? Then based 
on the spatiotemporal expression profile of Wnt/-catenin pathway we asked the second question 
which was 2.) can we switch the hepatic zonal phenotype by modulating Wnt/-catenin pathway 
during development?  
In this thesis I have demonstrated a comprehensive expression profile of members in Wnt/-catenin 
pathway using in situ hybridization. The temporal expression of both Wnt ligands and -catenin 
suggested they may exert diverse effects on hepatic differentiation. Additionally I have shown 
detailed expression of the perivenous marker, GS, and the periportal marker, CPS using 
immunohistochemistry and western blotting. -catenin has been reported to be declined after E14.5 
and remained undetectable at perinatal stages (Micsenyi et al, 2004). However both 
cytoplasmic/nuclear fractionation data and immunohistochemical analysis showed clear nuclear 
accumulation of -catenin between E17.5 and E18.5. This -catenin activation at perinatal stage is 
also suggested to correlate with the induction of GS expression. There are 19 Wnt genes and 10 
Frizzled genes identified so far in the mice. The dynamic expression patterns of these Wnt genes 
during development strongly suggest their heterogenic functions to regulate growth and 
differentiation. Here we have established the in situ hybridization technique however only 
demonstrated 4 Wnt genes and 2 Frizzled genes due to the limited time. More riboprobes for the rest 
of the members in Wnt pathway including the inhibitors should be generated and detected to provide 
a full circle of how Wnts signalling pathway regulated the mouse liver development.          
Based on the observation of expression profile of -catenin, CPS and GS,  We went on to answer the 
second question: can we switch the hepatic zonation phenotype by modulating Wnt/-catenin 
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pathway during development? We attempted the question from two strategies including in vivo by 
generating conditional deletion mouse of Apc and -catenin and in vitro by establishing E11.5 liver 
buds culture system and then subsequently altering the Wnt/-catenin pathway. The conditional 
deletion strategy was designed for deletion of Apc or -catenin by AhCre-mediated recombination. 
In the AhCre transgenic line, Cre expression is under the control of the Cyp1A1 promoter element 
that is normally transcriptional silent but can be up-regulated in response to lipophilic xenobiotics 
such as -napthoflavone (NF) (Matsushita et al., 1993). We successfully delete Apc at different 
embryonic stages and for the first time, we demonstrate that Apc deletion during mouse embryonic 
development would perturbs the establishment of liver zonation. Additionally, we showed Apc 
deletion will lead to liver proliferation and an increase of ductal-like structures. The canonical Wnt 
pathway has been shown to regulate the Notch pathway genes in intestinal adenomas (Ungerback et 
al, 2011). Notching signalling has been implicated in the formation of bile ducts composed of 
cholangiocytes by altering the expression of liver-enriched transcription factor, HNF1(Tanimizu 
and Miyajima, 2004. Here we showed Apc deletion induced ductal phenotype during mouse 
development indicated by up regulation of Sox9 protein expression. We also showed the activation 
of Notch downstream target genes including Hes1, Hey1 and manic fringe after Apc gene deletion. 
Based on the previous studies and our result, we suggested that Wnt/-catenin pathway induces 
ductal formation through activating Notching signalling pathway. However more experiments are 
needed to prove the hypothesis such as the analysis of ductal formation in embryonic livers dissected 
from Apc/Notch double deletion animals.     
The second strategy to prove Wnt/-catenin pathway plays critical role in regulating embryonic liver 
zonation is by manipulating the culture environment of dissected E11.5 liver buds. Ectopic 
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expression of transgene was been found to be difficult due to the nature that the nascent liver cells or 
hepatoblasts are surrounded by the mesenchymal cells which are notoriously easy to transfect in the 
culture. Here we took advantage of a well-established system in our lab of amplification and 
purification of high titre of adenoviral vectors to carry the genes of interest into the culture buds. The 
paracrine property of Wnt ligands also makes it suitable to more efficiently manipulate the 
Wnt/-catenin pathway in liver culture. Here we show GS increased and CPS decreased in liver buds 
cultured for 5 days with the supplement of ITS and then infected with adenovirus carrying Wnt1 
gene. Infection with adenovirus carrying Wnt antagonist DKK1 leads to decrease of GS and increase 
of CPS. This model provides us a feasible tool to investigate more detail mechanism of zonation 
regulation during mouse development. To further improve the in vitro culture systems, the effects of 
addition of soluble factors such as nicotinamide (Sato et al., 1999), hepatic growth factors and 
cytokines or cultured with extracellular proteins including type I collagen and type IV collagen 
should be further evaluated in the future.   
The last part of my thesis was to characterize the molecular mechanism of conversion of pancreatic 
AR42J-B13 cells to the hepatocyte-like cells. Transdifferentiation is the conversion of one 
differentiated cell type to another and may occur either with or without cell division. Our lab has 
established a model of transdifferentiation by culturing AR42J-B13 cells with synthetic 
glucocorticoid dexamethasone (Dex) for 2 weeks. The pancreatic cells can then transdifferentiate 
into hepatocytes and start expressing hepatocyte markers such as glucose-6-phosphatase, transferrin 
(TFN) and albumin. The C/EBP-β has also been identified as the molecular basis of the switch. 
Although transfection of C/EBPcaused a similar hepatic transdifferentiation programme to 
treatment of Dex, it did not cause the same degree of morphological flattening suggesting that 
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additional factors may be required to produce a more differentiated hepatic phenotype from 
pancreatic cells. HNF4became a potential candidate due to transdifferentiated cells induced by 
Dex also showed nuclear expression of HNF4To test the role of the liver-enriched transcription 
factor HNF4 we co-expressed C/EBP and HNF4 in B13 cells by using adenoviral infection. 
From morphology changing and immunostaining for hepatic markers we showed that ectopic 
expressed HNF4 and C/EBPcould induce a more differentiated hepatic phenotype of B13 cells. 
The disadvantages of RT-PCR include its complexity and problems associated with its sensitivity, 
reproducibility, and specificity. Moreover, it suffers from the problems inherent in traditional PCR 
when it is used as a quantitative method (Bustin, 2000). However, the introduction of real-time 
RT-PCR and the availability of modern equipment provide extended possibilities for the accurate 
quantification of mRNA species. Real-time RT-PCR allows the determination of the initial template 
concentration and, therefore, an accurate estimation of cell number. Real-time RT-PCR has several 
advantages over other PCR-based quantification approaches, including elimination of post 
amplification handling, easier automation, and processing of large numbers of samples. In addition, 
it has a very large dynamic range of template determination (around 6 orders of magnitude) (Heid et 
al., 1996). Therefore, as the real-time PCR assay provides more accurate and precise data it should 
be considered as a potential technique to apply in future experiments.  
Confocal microscopy is an optical imaging technique used to increase the optical resolution and 
contrast of a micrograph by using point illumination and a spatial pinhole to eliminate out-of-focus 
light in specimens that are thicker than the focal plane. It enables the reconstruction of 
three-dimensional structures from the obtained images. This technique has gained popularity in the 
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